Chronic pancreatitis

K11_CHRONPANC

alcoholic pancreatitis: Acute or chronic inflammation of the pancreas due to excessive alcohol drinking. Alcoholic pancreatitis usually presents as an acute episode but it is a chronic progressive disease in alcoholics.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K86.00, K86.01, K86.08, K86.1 Hospital discharge: ICD-9 — 5771 Hospital discharge: ICD-8 — 5771 Cause of death: ICD-10 — K86.00, K86.01, K86.08, K86.1 Cause of death: ICD-9 — 5771 Cause of death: ICD-8 — 5771 KELA reimbursements: KELA codes — 133 3 out of 7 registries used, show all original rules.	4948
4. Check minimum number of events None	4948
5. Include endpoints None	4948
6. Filter based on genotype QC (FinnGen only)	4948

Control definitions (FinnGen only)

Control exclude: K11_GALLBILPANC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_CHRONPANC
CONTROL_EXCLUDE	K11_GALLBILPANC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K86[0-1]
HD_ICD_9	5771
HD_ICD_8	5771
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K86[0-1]
COD_ICD_9	5771
COD_ICD_8	5771
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	133
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chronic pancreatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alcohol-induced chronic pancreatitis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	41461	11321	29733
Only index persons	32317	9387	22930
Unadjusted period prevalence (%)
Whole population	0.69	0.32	0.83
Only index persons	0.72	0.35	0.88
Median age at first event (years)
Whole population	53.49	58.70	51.48
Only index persons	53.93	58.91	51.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4948	1601	3347
Unadjusted period prevalence (%)	1.17	0.55	1.48
Median age at first event (years)	57.41	59.39	56.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4336: Matched controls
43361

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

+∞

323.0

1947

103

Kela drug reimbursment

Diabetes, insulin-treated

4.0

323.0

2041

7818

UJK02

NOMESCO Finland

ERCP

173.0

323.0

623

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

143.0

323.0

561

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

6764.2

323.0

597

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

80.2

323.0

542

K85

ICD-10 Finland

Acute pancreatitis

707.9

323.0

903

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

7.9

323.0

969

1524

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.1

323.0

1251

2705

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

5.1

323.0

2308

7947

K86.1

ICD-10 Finland

Other chronic pancreatitis

15659.2

323.0

1165

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

203.4

323.0

488

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

31.4

323.0

713

270

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

112.5

323.0

380

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

97.6

323.0

583

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

7.5

323.0

974

1604

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

626.2

323.0

501

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

56.8

323.0

467

R10.1

ICD-10 Finland

Pain localized to upper abdomen

6.3

323.0

1299

2753

A09AA02

ATC

multienzymes (lipase, protease etc.)

477.9

323.0

1993

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

10472.8

323.0

1876

JN3AD

NOMESCO Finland

Abdominal CT examination

7.8

323.0

909

1421

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.1

323.0

1994

7471

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4935.9

323.0

829

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

2159.6

323.0

414

JN3BD

NOMESCO Finland

Extensive abdominal CT

7.8

323.0

1225

2091

K86.3

ICD-10 Finland

Pseudocyst of pancreas

+∞

323.0

405

JLC30

NOMESCO Finland

Pancreatoduodenectomy

424.8

323.0

460

K83.1

ICD-10 Finland

Obstruction of bile duct

+∞

323.0

385

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

8.7

323.0

971

1393

A10AE04

ATC

insulin glargine; parenteral

6.7

323.0

1121

2131

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

178.4

317.2

330

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

+∞

313.4

297

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.7

305.3

1808

7035

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

1585.4

302.4

291

130

Kela drug reimbursment

Malignant tumour

5.7

291.3

937

1985

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

128.8

290.7

311

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

53.4

279.5

336

K85.8

ICD-10 Finland

Other acute pancreatitis

+∞

276.0

262

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

+∞

274.9

261

N02AX02

ATC

tramadol; systemic, rectal

3.1

274.9

2482

12933

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

180.5

260.4

271

A02BC02

ATC

pantoprazole; systemic

3.2

253.7

3251

20990

K86.8

ICD-10 Finland

Other specified diseases of pancreas

+∞

246.2

234

K83.0

ICD-10 Finland

Cholangitis

1246.2

243.9

236

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

9.8

237.0

507

580

TPH04

NOMESCO Finland

Cathetrisation of vein

3.4

229.5

1411

5385

WX302

NOMESCO Finland

Thoracal epidural anesthesy

7.1

227.9

601

959

A03FA01

ATC

metoclopramide; systemic, rectal

3.5

226.4

1284

4593

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

29.0

224.0

308

114

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

565.8

219.3

216

N02AA05

ATC

oxycodone; systemic

3.8

211.4

1065

3430

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.1

208.5

1522

6485

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

+∞

202.7

193

T90

ICPC

Diabetes non-insulin dependent

3.0

197.1

1508

6579

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.5

196.6

425

490

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

28.1

194.9

270

102

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

193.3

2363

13641

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.4

192.4

1129

4068

T89

ICPC

Diabetes insulin dependent

7.9

191.0

462

641

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

331.3

191.0

192

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

14.0

188.6

334

257

N07BB01

ATC

disulfiram; oral

6.2

187.0

548

996

J01MA12

ATC

levofloxacin; systemic

3.2

184.7

1207

4687

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.8

170.5

627

1475

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

66.5

169.9

197

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

294.4

167.0

169

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.1

164.4

567

1242

SPAT1262

SPAT

Handing over of treatment supplies

3.0

164.1

1190

4900

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

12.0

159.1

302

269

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

17.8

158.1

253

150

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

6.6

156.9

433

721

F10.25

ICD-10 Finland

Alcohol dependence continuous use

10.4

155.8

318

327

N06AX11

ATC

mirtazapine; oral

2.5

152.7

1629

8372

F10.20

ICD-10 Finland

Alcohol dependence currently independent

9.4

151.3

326

370

N05CF01

ATC

zopiclone; oral

2.5

150.5

1681

8838

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

10.1

144.4

300

318

A10AE05

ATC

insulin detemir; parenteral

5.0

143.3

496

1083

TPH07

NOMESCO Finland

Cathetrisation of artery

3.6

143.3

737

2336

K86.2

ICD-10 Finland

Cyst of pancreas

+∞

139.3

133

JN4BD

NOMESCO Finland

Extensive body CT

3.3

134.9

767

2619

JKA20

NOMESCO Finland

Cholecystectomy

29.1

134.3

184

P15

ICPC

Chronic alcohol abuse

6.7

133.2

360

579

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

132.7

1430

7261

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.6

130.4

406

782

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

73.3

130.4

149

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

30.7

128.9

174

A10BA02

ATC

metformin; oral

2.3

126.6

1527

8166

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.5

125.2

663

2133

A04AA02

ATC

granisetron; systemic, transdermal

4.4

125.0

491

1215

JAH01

NOMESCO Finland

Laparoscopy

6.9

124.7

330

514

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

124.6

119

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

23.6

124.6

181

ZXD05

NOMESCO Finland

Urgent procedure

2.3

123.9

1528

8244

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.2

122.9

407

841

F10.24

ICD-10 Finland

Alcohol depence active use

10.3

121.6

248

253

JN4CD

NOMESCO Finland

Very extensive body CT

5.6

121.3

380

736

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

4.2

121.1

498

1287

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

121.0

703

2422

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

132.9

120.8

129

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.8

120.2

364

676

R4190

NOMESCO Finland

Nutritional therapy

6.5

117.3

322

527

N05AH04

ATC

quetiapine; oral

2.8

115.3

877

3609

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

577.9

114.5

113

R10.0

ICD-10 Finland

Acute abdomen

7.7

113.3

276

380

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

383.8

113.0

113

N05BA04

ATC

oxazepam; oral

2.4

111.4

1188

5897

A02BC01

ATC

omeprazole; systemic

2.3

110.9

1351

7159

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

109.8

948

4193

N05BA01

ATC

diazepam; systemic, rectal

2.9

109.5

789

3129

A02BC05

ATC

esomeprazole; systemic

2.1

106.4

1855

11474

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.6

104.7

256

354

E13

ICD-10 Finland

Other specified diabetes mellitus

67.9

103.1

119

K92.0

ICD-10 Finland

Haematemesis

7.0

101.0

262

395

A06AD11

ATC

lactulose; oral

2.7

100.5

773

3177

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

94.1

99.5

110

UJF32

NOMESCO Finland

Coloscopy

2.2

99.2

1278

6880

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.2

98.7

280

477

K85.1

ICD-10 Finland

Biliary acute pancreatitis

980.1

98.4

L01BC06

ATC

capecitabine; oral

5.3

97.7

317

636

N03AX16

ATC

pregabalin; oral

2.3

97.3

1167

6066

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

+∞

97.2

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

+∞

96.2

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

26.9

95.3

133

K70.1

ICD-10 Finland

Alcoholic hepatitis

20.2

95.3

145

D02

ICPC

Abdominal pain epigastric

4.9

94.9

332

723

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

94.7

835

3701

N02BE01

ATC

paracetamol; systemic, rectal

2.3

94.6

3682

30746

N05BA02

ATC

chlordiazepoxide; systemic

6.1

94.1

269

462

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.1

93.8

204

233

N06AB04

ATC

citalopram; systemic

2.3

93.5

1030

5123

Z51.5

ICD-10 Finland

Palliative care

3.8

93.3

431

1224

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

93.2

1526

9054

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.1

93.0

237

348

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

10.0

92.2

190

197

WZC30

NOMESCO Finland

Teaching

2.6

92.1

749

3167

R50.9

ICD-10 Finland

Fever, unspecified

2.6

91.1

746

3164

R11

ICD-10 Finland

Nausea and vomiting

3.7

89.4

423

1225

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.1

88.1

1361

7843

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

44.6

88.1

109

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.9

87.7

258

459

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

87.6

1175

6373

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

9.7

87.5

184

198

N05CD07

ATC

temazepam; oral

2.7

87.4

698

2909

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.0

87.3

254

446

P01AB01

ATC

metronidazole; oral, rectal

2.0

87.1

1618

10026

WX002

NOMESCO Finland

Sedation and analgesia

2.3

86.8

998

5041

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.0

86.8

376

1008

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

+∞

86.7

C03CA01

ATC

furosemide; systemic

2.1

86.0

1299

7401

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

85.9

590

2239

K81.0

ICD-10 Finland

Acute cholecystitis

153.1

85.4

JAH00

NOMESCO Finland

Laparotomy

6.2

85.2

241

408

ZXE00

NOMESCO Finland

One hour or less

1.9

84.9

1729

11062

JN4AD

NOMESCO Finland

Body CT examination

3.1

84.9

515

1798

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

84.4

757

3364

J01MA02

ATC

ciprofloxacin; systemic

1.9

84.3

1795

11665

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

25.4

84.1

119

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

83.5

925

4579

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.4

83.1

190

236

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.9

82.9

574

2188

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

51.1

82.9

100

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

+∞

82.5

JLC10

NOMESCO Finland

Distal pancreatectomy

55.6

82.5

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

128.3

82.2

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

9.1

82.2

179

205

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

5.3

81.8

263

520

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

72.9

81.6

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

+∞

81.5

D76

ICPC

Malignant neoplasm pancreas

55.1

81.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.5

81.4

253

481

B01AB05

ATC

enoxaparin; parenteral

2.0

80.8

1395

8342

WX892

NOMESCO Finland

Monitored bed care

3.1

80.6

484

1676

K29.2

ICD-10 Finland

Alcoholic gastritis

32.2

80.6

107

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.5

79.5

301

709

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

78.7

1341

7958

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.3

78.6

842

4085

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.4

78.2

302

725

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

10.3

76.7

155

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

265.2

76.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

76.6

496

1806

N06AX16

ATC

venlafaxine; oral

2.6

74.9

639

2747

H02AB02

ATC

dexamethasone; systemic

2.7

74.3

564

2267

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

730.3

73.4

AA1AD

NOMESCO Finland

CT of head and brain

2.0

72.9

1148

6570

J01DB01

ATC

cefalexin; oral

2.0

72.8

3459

28950

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.5

72.7

178

246

A10AE06

ATC

insulin degludec; parenteral

5.1

71.8

239

491

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

19.9

71.6

109

A02BC03

ATC

lansoprazole; oral

1.9

71.3

1308

7919

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

8.7

71.1

158

187

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

70.4

824

4145

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

70.3

1564

10133

ZX120

NOMESCO Finland

Intravenous

2.8

70.2

509

1985

P16

ICPC

Acute alcohol abuse

7.0

69.7

178

262

TKC20

NOMESCO Finland

Catheterisation of bladder

3.0

69.2

435

1547

N05AB01

ATC

dixyrazine; systemic

8.3

69.2

159

199

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

+∞

68.9

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

678.6

68.2

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

146.4

68.1

R4110

NOMESCO Finland

Physiotherapy

1.9

65.7

1214

7330

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.6

65.5

175

274

E87.6

ICD-10 Finland

Hypokalaemia

4.9

65.1

222

468

UJD02

NOMESCO Finland

Gastroscopy

3.7

65.0

303

861

WX402

NOMESCO Finland

General anaesthesia

2.2

64.8

775

3921

JMA10

NOMESCO Finland

Transabdominal total splenectomy

16.9

64.4

104

Z3226

NOMESCO Finland

Physiotherapist

2.1

64.4

868

4623

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

4.3

63.8

249

603

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

5.2

63.6

205

406

A02BA02

ATC

ranitidine; systemic

2.1

63.6

897

4867

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

80.3

63.2

C10AC01

ATC

colestyramine; oral

5.9

63.2

183

319

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.0

63.1

137

156

Z72.1

ICD-10 Finland

Alcohol use

7.4

63.0

155

216

57710

ICD-8 Finland

Diseases of pancreas, Pancreatitis chronica recidivans

+∞

62.6

D01

ICPC

Abdominal pain/cramps general

2.8

62.3

445

1714

WX110

NOMESCO Finland

Local anesthesy

1.7

61.8

2794

22223

Z2446

NOMESCO Finland

Social worker

3.1

61.5

366

1251

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

60.7

689

3392

SPAT1254

SPAT

Administration of medicine

2.3

60.4

655

3159

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.6

59.9

285

822

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.3

59.8

322

1024

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.8

59.7

266

726

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.9

59.5

130

150

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.8

59.3

268

741

K92.1

ICD-10 Finland

Melaena

3.3

59.2

317

1004

V03AA01

ATC

5.2

58.1

189

378

K81.9

ICD-10 Finland

Cholecystitis, unspecified

125.7

57.9

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

57.4

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

5.5

56.9

176

332

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

565.3

56.7

Z3231

NOMESCO Finland

Registered nurse

1.8

56.6

1201

7530

57719

ICD-8 Finland

Diseases of pancreas, Pancreatitis chronica NUD

+∞

56.4

B01AB10

ATC

tinzaparin; parenteral

2.9

56.2

375

1379

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

52.3

56.0

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

7.9

55.8

131

170

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

55.2

497

2177

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

544.7

54.7

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

544.7

54.7

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

22.3

54.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.1

53.7

313

1053

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

534.4

53.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

53.3

1228

7880

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

10.0

53.3

109

112

N06AB03

ATC

fluoxetine; oral

2.3

52.5

556

2638

N06AB10

ATC

escitalopram; oral

2.0

52.3

767

4188

JDE00

NOMESCO Finland

Gastrojejunostomy

49.1

52.1

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.1

51.8

306

1036

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.7

51.7

184

406

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

56.2

51.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

51.0

526

2462

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

111.4

50.9

E10

ICD-10 Finland

Type 1 diabetes mellitus

6.0

50.8

146

252

S18

ICPC

Laceration/cut

1.6

50.7

1756

12659

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

34.7

50.1

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.1

50.0

126

182

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.8

49.7

145

255

N03AX12

ATC

gabapentin; oral

2.1

49.6

677

3584

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

49.4

549

2656

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

11.7

49.0

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

48.9

342

1294

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.3

48.6

190

460

A41.9

ICD-10 Finland

Sepsis, unspecified

3.8

48.4

217

595

WX882

NOMESCO Finland

High dependency care

4.4

48.4

184

434

N06AX21

ATC

duloxetine; oral

2.4

48.4

458

2052

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

6.9

48.1

123

182

E16.89

ICD-10 Finland

Other specified disorders of pancreatic internal secretion

+∞

48.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

47.7

932

5632

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.4

47.5

240

725

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.5

47.5

236

704

JLC50

NOMESCO Finland

Atypical pancreatectomy

472.8

47.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

47.2

310

1125

K30

ICD-10 Finland

Functional dyspepsia

2.4

47.1

428

1876

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

103.2

46.8

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.6

46.6

223

645

A10BH01

ATC

sitagliptin; oral

2.3

46.6

484

2269

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

13.7

46.5

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.8

46.3

208

571

B03BA03

ATC

hydroxocobalamin; parenteral

3.0

46.2

289

1018

N05AA02

ATC

levomepromazine; systemic

3.1

46.0

265

883

H04AA01

ATC

glucagon; nasal, parenteral

4.9

45.9

156

328

C07AA05

ATC

propranolol; systemic

1.9

45.6

752

4270

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.3

45.6

143

275

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

45.3

1534

10888

E13.4

ICD-10 Finland

Other specified diabetes mellitus, with neurological complications

232.3

45.0

N07BA03

ATC

varenicline; oral

2.9

44.9

291

1049

6663

FHL

Cholecystectomy and cholangiography

158.3

44.9

JLT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pancreatic duct

+∞

44.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

44.6

2448

19599

A10BB12

ATC

glimepiride; oral

2.5

44.6

370

1544

SPAT1265

SPAT

Breathalyser

7.6

44.4

106

142

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

442.1

44.3

A04AA01

ATC

ondansetron; systemic, rectal

2.7

44.3

323

1253

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

44.3

446

2055

WX004

NOMESCO Finland

Patient-controlled sedation

18.0

44.1

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.0

44.0

182

465

K70.0

ICD-10 Finland

Alcoholic fatty liver

9.0

44.0

108

5771D

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA NUD]

+∞

43.8

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

8.5

43.6

116

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

43.5

1094

7123

Z2221

NOMESCO Finland

Medical doctor

1.7

43.3

1102

7205

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

116.2

42.8

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

+∞

42.8

5771C

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA RECIDIVANS]

+∞

42.8

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

12.6

42.6

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

421.6

42.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

42.0

810

4843

5742A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

41.7

WW500

NOMESCO Finland

Blood transfusion

3.3

41.7

222

698

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.1

41.5

239

795

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

41.4

496

2472

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.7

41.0

186

515

K29.7

ICD-10 Finland

Gastritis, unspecified

3.6

41.0

196

567

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.8

41.0

181

490

R53

ICD-10 Finland

Malaise and fatigue

1.8

40.9

771

4571

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

111.1

40.8

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

7.9

40.7

123

TJK01

NOMESCO Finland

Laparoscopic cholangiography

+∞

40.7

N05BA12

ATC

alprazolam; oral

2.2

40.7

453

2186

K59.1

ICD-10 Finland

Functional diarrhoea

3.1

40.4

236

792

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.3

40.1

136

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

40.0

460

2253

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

39.9

473

2346

C07AB07

ATC

bisoprolol; oral

1.5

39.9

1945

14974

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

6.6

39.7

105

163

5771B

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA NONALCOHOLICA NUD]

+∞

39.6

C25

ICD-10 Finland

Malignant neoplasm of pancreas

58.1

39.3

EBA00

NOMESCO Finland

Extraction of tooth

1.6

39.0

1320

9278

S06.0

ICD-10 Finland

Concussion

2.2

39.0

439

2125

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

39.0

599

3296

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

38.9

1872

14335

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

11.2

38.8

N06AB06

ATC

sertraline; oral

2.2

38.8

431

2076

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

38.8

488

2482

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.3

38.7

147

347

A06AH03

ATC

naloxegol; oral

6.4

38.6

104

166

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

18.7

38.3

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

38.1

305

1245

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

38.0

190

570

K80.8

ICD-10 Finland

Other cholelithiasis

21.0

37.8

J01DA01

ATC

[U] cefalexin; systemic

1.5

37.6

2453

20059

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

3.4

37.6

187

559

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

5.4

37.5

116

220

A10AA02

ATC

3.3

37.5

197

614

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

37.4

206

664

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

37.1

331

1432

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

370.4

37.0

E13.1

ICD-10 Finland

Other specified diabetes mellitus, with ketoacidosis

82.8

36.8

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

6.2

36.8

102

169

SPAT1255

SPAT

Intravenous administration of medicine

2.4

36.7

321

1376

E86

ICD-10 Finland

Volume depletion

4.3

36.4

141

339

N06AA09

ATC

amitriptyline; systemic

2.1

36.4

426

2097

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

36.2

308

1299

H01CB02

ATC

octreotide; parenteral

21.4

36.1

R18

ICD-10 Finland

Ascites

4.5

36.0

131

297

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

35.9

1089

7407

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.9

35.9

229

816

J01FF01

ATC

clindamycin; systemic

1.6

35.8

1107

7566

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

186.5

35.8

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

35.5

227

810

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

35.5

1550

11530

N06AX03

ATC

mianserin; oral

2.8

35.3

234

854

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.5

35.3

148

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

35.1

1958

15366

N05CF02

ATC

zolpidem; oral

1.8

35.0

688

4116

TK800

NOMESCO Finland

Hemodialysis

3.9

34.9

150

397

C08CA01

ATC

amlodipine; oral

1.5

34.9

1486

10974

A28

ICPC

Limited function/disability NOS

1.9

34.7

580

3285

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.6

34.6

103

187

SPAT1263

SPAT

Sampling

1.5

34.5

1597

12018

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

51.7

34.4

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

34.4

208

713

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

6.1

34.4

161

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.3

34.2

E14.1

ICD-10 Finland

Unspecified diabetes mellitus, with ketoacidosis

29.0

34.2

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

34.1

677

4058

B81

ICPC

Anaemia vit B12/folate deficiency

3.1

34.0

191

625

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

76.8

33.8

H02AB06

ATC

prednisolone; systemic

1.5

33.8

1824

14174

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.6

33.8

160

460

N06AA12

ATC

doxepin; systemic

2.6

33.8

260

1039

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

9.7

33.7

E0000UV

ATC

1.5

33.7

1442

10640

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

33.5

316

1404

S01.0

ICD-10 Finland

Open wound of scalp

2.2

33.5

366

1745

D11

ICPC

Diarrhoea

2.1

33.1

380

1854

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

18.4

33.1

WX872

NOMESCO Finland

Intensive care

2.5

32.7

277

1164

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

13.8

32.5

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

54.7

32.3

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

32.2

393

1966

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.7

32.2

112

243

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

11.7

31.8

E16.9

ICD-10 Finland

Disorder of pancreatic internal secretion, unspecified

88.2

31.7

M79.6

ICD-10 Finland

Pain in limb

1.5

31.7

1298

9449

W19

ICD-10 Finland

Unspecified fall

2.1

31.7

396

2001

S22.3

ICD-10 Finland

Fracture of rib

2.3

31.6

318

1460

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

31.5

174

563

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.7

31.4

140

383

5772A

ICD-9 Finland

Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]

+∞

31.3

D06

ICPC

Abdominal pain localized other

2.4

31.0

285

1252

B01AB04

ATC

dalteparin; parenteral

2.7

31.0

218

827

JLD22

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst to jejunum

315.0

30.9

C03DA01

ATC

spironolactone; oral

2.0

30.8

452

2434

E13.2

ICD-10 Finland

Other specified diabetes mellitus, with renal complications

110.8

30.7

R63.4

ICD-10 Finland

Abnormal weight loss

3.1

30.6

174

573

5771A

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA NONALCOHOLICA RECIDIVANS]

+∞

30.2

S97

ICPC

Chronic ulcer skin

2.5

30.2

253

1058

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.6

30.2

122

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

30.1

634

3861

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

5.0

30.0

203

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

30.0

463

2538

E87.5

ICD-10 Finland

Hyperkalaemia

4.6

29.9

106

235

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

29.8

189

671

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.3

29.7

114

273

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

156.0

29.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

29.6

677

4226

J01MA14

ATC

moxifloxacin; systemic

2.0

29.3

387

1997

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

29.3

822

5433

57409

ICD-8 Finland

Cholelithiasis, Unspecified

+∞

29.2

A10AB06

ATC

insulin glulisine; parenteral

5.7

29.2

151

A05AA02

ATC

ursodeoxycholic acid; oral

7.0

29.2

106

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

29.1

274

1214

UJK12

NOMESCO Finland

Peroral cholangioscopy

57.1

29.1

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

28.9

254

1090

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.4

28.9

146

443

JLD00

NOMESCO Finland

Pancreaticojejunostomy

293.8

28.8

E87.2

ICD-10 Finland

Acidosis

8.5

28.6

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

10.5

28.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.6

28.5

102

228

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

28.5

294

1365

A01

ICPC

Pain general/multiple sites

2.2

28.4

293

1359

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.2

28.3

109

262

N05BE01

ATC

buspirone; oral

3.1

28.3

162

537

E14

ICD-10 Finland

Unspecified diabetes mellitus

13.0

28.3

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

28.3

208

809

K02.1

ICD-10 Finland

Caries of dentine

1.4

28.2

2092

17101

5770E

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICAHAEMORRHAGICA]

+∞

28.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

28.0

1119

8055

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

28.0

319

1549

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

27.9

439

2421

RD210

NOMESCO Finland

4.6

27.9

220

L03AA02

ATC

filgrastim; parenteral

3.4

27.8

139

418

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

27.7

365

1882

107

Kela drug reimbursment

Pernicious anaemia

4.1

27.6

110

273

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.6

27.5

128

364

A02BA04

ATC

nizatidine; systemic

2.1

27.3

319

1565

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

27.2

1477

11336

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

+∞

27.1

304

Kela drug reimbursment

Dornase alfa

+∞

27.1

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

11.2

27.0

A03DA02

ATC

pitofenone and analgesics; systemic

4.8

27.0

196

K86

ICD-10 Finland

Other diseases of pancreas

62.4

26.9

K29.1

ICD-10 Finland

Other acute gastritis

5.4

26.9

154

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

26.8

547

3290

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

26.8

232

989

TJK00

NOMESCO Finland

Intraoperative cholangiography

97.3

26.7

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

140.9

26.6

M54.5

ICD-10 Finland

Low back pain

1.5

26.6

1172

8602

XF612

NOMESCO Finland

Measurement of central venous pressure

18.0

26.5

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

46.0

26.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

26.5

262

1192

J02AC01

ATC

fluconazole; systemic

1.5

26.4

1156

8470

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.0

26.3

107

271

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

26.3

180

669

SPAT1301

SPAT

No procedures

1.5

26.3

1172

8621

A11CC03

ATC

alfacalcidol; systemic

3.4

26.2

130

389

A41.8

ICD-10 Finland

Other specified sepsis

4.4

26.1

226

E16.19

ICD-10 Finland

Other specified hypoglycaemia

11.2

26.0

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

26.0

259

1181

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

26.0

305

1499

L17

ICPC

Foot/toe symptom/complaint

1.6

26.0

898

6231

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

25.9

435

2451

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.2

25.6

240

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

33.2

25.5

WX290

NOMESCO Finland

Other blockade of nerve

1.4

25.4

1545

12077

205

Kela drug reimbursment

Chronic hypertension

1.5

25.4

1114

8154

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

25.4

222

949

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.4

25.3

126

379

W10

ICD-10 Finland

Fall on and from stairs and steps

2.4

25.2

215

908

5770C

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]

+∞

25.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

24.8

617

3928

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

7.2

24.7

I81

ICD-10 Finland

Portal vein thrombosis

12.0

24.7

A10BK03

ATC

empagliflozin; oral

2.0

24.6

327

1691

A10AA01

ATC

3.1

24.4

139

458

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.3

24.4

125

384

F34.1

ICD-10 Finland

Dysthymia

2.9

24.3

149

519

WX730

NOMESCO Finland

Conventional respirator

3.8

24.1

104

278

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

24.1

146

505

C09AA05

ATC

ramipril; oral

1.5

24.0

1013

7336

E13.3

ICD-10 Finland

Other specified diabetes mellitus, with ophthalmic complications

56.3

24.0

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

5.1

24.0

150

K08.3

ICD-10 Finland

Retained dental root

2.0

23.9

315

1621

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.0

23.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

23.8

455

2676

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

23.8

207

884

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

241.2

23.7

JLA00

NOMESCO Finland

Exploration of pancreas

125.7

23.6

SPAT1240

SPAT

Therapeutic discussion

1.9

23.6

341

1820

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

23.5

2646

22970

H01CB03

ATC

lanreotide; parenteral

13.9

23.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

23.5

1408

10935

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

6.4

23.5

L28

ICPC

Limited function/disability (L)

1.7

23.5

559

3513

P03

ICPC

Feeling depressed

2.2

23.4

259

1241

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

23.3

238

1097

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

46.9

23.3

309

Kela drug reimbursment

Nalmefene and naltrexone

8.4

23.3

K75.0

ICD-10 Finland

Abscess of liver

15.3

23.2

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

9.0

23.2

D10

ICPC

Vomiting

2.6

23.1

174

688

WVA20

NOMESCO Finland

Medicine administration

3.3

23.1

117

357

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

23.1

811

5630

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.5

22.9

189

A10BH05

ATC

linagliptin; oral

2.4

22.9

203

874

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

13.0

22.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

22.8

368

2044

6662

FHL

Cholecystectomy

65.3

22.8

K20

ICD-10 Finland

Oesophagitis

3.9

22.8

247

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

5.9

22.7

110

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

22.7

332

1778

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

22.7

125

406

C24.02

ICD-10 Finland

Common bile duct

231.1

22.6

GBB00

NOMESCO Finland

Tracheostomy

4.5

22.6

183

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

22.5

1403

10955

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

22.5

287

1459

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.3

22.3

113

345

N05AD01

ATC

haloperidol; systemic

2.8

22.3

144

519

EBA30

NOMESCO Finland

Excision of root of tooth

2.1

22.2

249

1198

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

18.0

22.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

22.0

241

1149

JLW96

NOMESCO Finland

Other operation on pancreas

+∞

21.9

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

21.9

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

21.9

295

1532

Z71.8

ICD-10 Finland

Other specified counselling

1.5

21.8

791

5525

SPAT1247

SPAT

Outpatient detoxication and monitoring

7.1

21.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

21.7

318

1706

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

21.6

624

4120

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

7.5

21.6

N17.8

ICD-10 Finland

Other acute renal failure

4.7

21.5

156

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.5

21.4

169

683

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

21.4

413

2434

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

21.4

176

730

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.5

21.4

103

303

N03AF01

ATC

carbamazepine; oral, rectal

2.2

21.2

224

1050

V03AB30

ATC

5.0

21.2

141

A07AA02

ATC

nystatin; oral

2.2

21.2

233

1111

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.6

21.2

279

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.6

21.2

154

596

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.4

21.2

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.4

21.1

103

306

N03AX09

ATC

lamotrigine; oral

2.5

21.0

170

700

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.5

20.9

114

K29.8

ICD-10 Finland

Duodenitis

5.6

20.9

110

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

20.9

163

657

K65.0

ICD-10 Finland

Acute peritonitis

4.6

20.9

161

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.0

20.9

121

407

Z72.0

ICD-10 Finland

Tobacco use

3.0

20.9

126

435

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

20.9

521

3310

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

+∞

20.8

5740A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]

+∞

20.8

N06AA06

ATC

trimipramine; systemic

3.1

20.8

119

396

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

20.8

354

2001

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

20.8

103

310

J01GB01

ATC

tobramycin; inhalant, parenteral

37.4

20.7

R03BB04

ATC

tiotropium bromide; inhalant

1.8

20.7

412

2451

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.3

20.7

198

888

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.5

20.6

280

R06.0

ICD-10 Finland

Dyspnoea

1.5

20.6

893

6473

E13.0

ICD-10 Finland

Other specified diabetes mellitus, with coma

110.5

20.6

P01

ICPC

Feeling anxious/nervous/tense

2.0

20.6

256

1289

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

20.5

221

1046

N06AB05

ATC

paroxetine; oral

2.1

20.5

238

1165

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

20.4

110

353

WX704

NOMESCO Finland

Intubation

2.0

20.3

277

1443

A03

ICPC

Fever

1.7

20.3

497

3138

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

20.2

184

805

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.1

20.2

127

SPAT1227

SPAT

Substance abuse rehabilitation

6.1

20.2

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

20.2

199

903

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

5.7

20.2

103

K56.7

ICD-10 Finland

Ileus, unspecified

3.8

20.1

235

T74.1

ICD-10 Finland

Physical abuse

4.0

20.0

206

JAH33

NOMESCO Finland

Opening of laparostomy

13.7

20.0

WX610

NOMESCO Finland

Patient controlled analgesia

8.0

19.9

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

3.8

19.9

227

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

19.9

202

931

57408

ICD-8 Finland

Cholelithiasis, Alia definita

+∞

19.8

JLB96

NOMESCO Finland

Other incision, drainage or dilatation of pancreas

+∞

19.8

57401

ICD-8 Finland

Cholelithiasis, Cum cholecystitide chronica

+∞

19.8

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

19.8

411

2475

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

19.8

207

969

R52.0

ICD-10 Finland

Acute pain

2.9

19.8

121

423

N06AX05

ATC

trazodone; oral

3.2

19.6

104

330

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

17.8

19.5

TK810

NOMESCO Finland

Hemofiltration

6.3

19.5

A02BX02

ATC

sucralfate; oral

2.4

19.4

163

684

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

14.6

19.3

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

8.5

19.3

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

8.5

19.3

P18

ICPC

Medication abuse

7.6

19.3

D07AA02

ATC

hydrocortisone; topical

1.7

19.2

447

2784

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

4.1

19.1

186

N05AD03

ATC

melperone; systemic

4.1

19.0

187

JLA10

NOMESCO Finland

Biopsy of pancreas

70.2

18.7

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

18.7

254

1322

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

18.7

242

1239

RS221

NOMESCO Finland

3.9

18.7

200

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

18.6

127

474

K31.5

ICD-10 Finland

Obstruction of duodenum

23.8

18.6

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

100.5

18.6

K81.1

ICD-10 Finland

Chronic cholecystitis

190.7

18.5

B03XA02

ATC

darbepoetin alfa; parenteral

3.3

18.5

295

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

11.4

18.4

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

11.4

18.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

18.4

1301

10301

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.2

18.4

111

F32

ICD-10 Finland

Depressive episode

2.3

18.4

171

756

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.8

18.4

117

419

T08

ICPC

Weight loss

4.4

18.4

155

ZY010

NOMESCO Finland

Hospital outpatient

2.4

18.3

163

706

A03FA02

ATC

cisapride; oral, rectal

1.9

18.3

260

1378

R51.80

ICD-10 Finland

Headache

1.7

18.3

430

2680

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.3

18.3

286

R41.0

ICD-10 Finland

Disorientation, unspecified

2.6

18.3

131

505

I86.4

ICD-10 Finland

Gastric varices

44.2

18.2

A46

ICD-10 Finland

Erysipelas

1.6

18.2

552

3681

R55

ICD-10 Finland

Syncope and collapse

1.7

18.2

393

2394

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

21.8

18.1

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.4

18.1

148

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

10.4

18.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

18.1

1886

15868

F61.0

ICD-10 Finland

Mixed personality disorders

3.6

18.1

226

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.8

18.1

-1

NOMESCO Finland

1.4

18.0

1110

8573

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

18.0

2019

17167

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.2

18.0

306

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.1

18.0

177

R52.9

ICD-10 Finland

Pain, unspecified

1.8

17.9

295

1646

N05AF03

ATC

chlorprothixene; systemic

2.7

17.9

127

486

ZXA00

NOMESCO Finland

Right side

1.4

17.9

995

7544

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

22.8

17.7

5770B

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA HAEMORRHAGICA]

+∞

17.7

JLB98

NOMESCO Finland

Other transduodenal endosciopic incision, drainage or dilatation of pancreas

+∞

17.7

H3603, E103

ICD-10 Finland

4.2

17.7

161

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.4

17.7

251

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

17.7

171

769

N05AH03

ATC

olanzapine; systemic

2.0

17.7

228

1166

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1769

6716

3.54

307.65

4.9

3.5

mmol/l

0.8

38.56

1694

6294

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

960

1248

9.30

307.65

6.2

3.3

u/ml

1465.4

1504.1

0.01

870

1067

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1590

3891

5.55

307.65

6.0

2.4

umol/l

15.9

7.8

12.19

1435

3395

(3032080) INR in Blood by Coagulation assay

3080

16741

3.23

307.65

11.4

9.1

inr

1.2

1.3

3.34

901

4625

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3842

20168

5.05

307.65

16.5

6.0

umol/l

12.4

11.7

1.62

3718

19154

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2649

12541

3.39

307.65

6.1

3.1

u/l

47.1

35.2

2.43

2524

11858

(3023368) Bacteria identified in Blood by Culture

2464

11214

3.39

307.65

7.2

4.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3381

17153

4.07

307.65

10.5

4.8

g/l

32.9

35.5

105.73

3240

15915

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1610

3446

6.44

307.65

3.8

2.1

g/l

0.2

12.43

1520

3175

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

341

257

14.18

307.65

1.4

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

695

686

11.62

307.65

6.0

3.4

u/ml

593.6

1065.5

0.52

639

632

(3013005) Retinol [Moles/volume] in Serum or Plasma

256

110

24.49

307.65

2.7

1.3

umol/l

1.8

2.1

3.97

243

101

(3024980) IgG subclass 4 [Mass/volume] in Serum

477

493

10.60

307.65

2.5

1.3

g/l

1.0

0.9

0.84

315

393

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1510

5363

3.61

307.65

7.7

6.2

mmol/l

1.0

0.03

1452

5015

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3202

11570

6.01

307.65

7.0

2.3

u/l

67.7

56.2

6.22

3013

10658

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1574

3908

5.44

307.65

5.8

4.3

ug/l

17.6

28.3

0.81

1436

3233

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

254

120

22.26

307.65

2.7

1.2

umol/l

24.4

30.7

7.94

247

114

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1323

3281

5.14

307.65

8.1

1.9

u/l

194.5

33.9

1.64

1144

2823

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1818

837

33.76

307.65

1.9

1.3

ug/g

118.1

304.4

103.30

1081

493

(3014576) Chloride [Moles/volume] in Serum or Plasma

1427

5288

3.39

298.92

13.0

7.3

mmol/l

103.6

104.5

8.28

1404

5173

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3296

19720

3.01

288.03

12.1

7.0

mmol/l

1.2

32.28

2771

16650

(3013826) Glucose [Moles/volume] in Serum or Plasma

3713

23884

3.22

281.54

10.4

4.7

mmol/l

8.0

6.8

102.34

3603

22446

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3078

17991

2.88

276.49

11.4

6.2

mmol/l

1.2

27.59

2923

16298

(3023183) Ammonium ion [Moles/volume] in Plasma

485

868

6.09

261.89

3.3

2.7

umol/l

38.1

35.5

0.80

407

739

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

468

811

6.27

261.16

2.0

1.7

nmol/l

0.6

0.9

13.07

387

680

(3033658) Prothrombin time (PT) actual/Normal

2083

10197

2.80

259.56

8.7

3.8

84.3

88.0

9.60

2028

9960

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

327

391

8.88

254.69

1.4

1.3

nmol/l

0.9

1.5

15.18

291

350

(3042936) Bacteria identified in Isolate by Culture

1415

5691

3.08

252.80

2.8

2.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

894

2702

3.82

252.79

1.9

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1921

9652

2.62

219.06

2.8

2.2

mg/l

3.0

2.9

0.38

1710

8197

(3022948) Iron [Moles/volume] in Serum or Plasma

1439

6253

2.84

218.99

3.3

2.6

umol/l

11.4

13.2

16.72

1369

5809

(3020779) Urea [Moles/volume] in Serum or Plasma

1055

3886

3.18

215.90

9.4

7.6

mmol/l

9.6

10.1

1.52

1011

3701

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

316

441

7.59

215.79

4.6

3.3

nmol/l

6.4

18.6

0.49

310

434

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4179

30768

3.31

212.36

19.5

7.3

u/l

105.8

76.6

85.02

4056

28952

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1294

5449

2.86

207.55

3.3

2.7

21.7

23.2

2.49

1109

4657

(3018418) pH of Serum or Plasma

2148

11619

2.50

206.68

6.7

4.2

7.4

0.66

518

2206

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1348

5818

2.81

206.16

3.3

2.6

g/l

2.2

2.3

5.17

1281

5411

(3044640) Blood type and Crossmatch panel - Blood

2201

12189

2.45

199.23

4.0

2.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

981

3698

3.06

190.90

10.9

7.4

mmol/l

1.6

1.4

3.98

955

3558

(3013650) Neutrophils [#/volume] in Blood by Automated count

3362

22784

2.48

189.08

15.4

9.3

e9/l

4.5

4.1

16.73

3037

19780

(3000991) Gas panel - Venous blood

932

3548

3.00

177.19

13.6

8.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2844

18220

2.32

177.04

6.1

4.0

—

(3009508) Creatinine [Moles/volume] in Urine

2277

13307

2.32

176.20

4.1

3.2

mmol/l

6.7

8.0

38.92

1953

11219

(3021447) Carbon dioxide [Partial pressure] in Venous blood

977

3862

2.91

173.15

6.6

3.8

kpa

5.8

1.21

951

3742

(3017315) Amylase [Enzymatic activity/volume] in Urine

182

165

11.41

172.91

1.9

1.1

u/l

534.8

267.5

1.20

155

157

(3002032) Base excess in Venous blood by calculation

975

3859

2.90

172.32

6.6

3.9

mmol/l

1.4

1.9

2.49

813

3096

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1366

6443

2.55

170.39

2.2

1.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

241

323

7.79

170.10

1.9

1.2

g/l

6.5

7.0

0.96

124

240

(3024139) IgG subclass 3 [Mass/volume] in Serum

241

323

7.79

170.10

1.9

1.2

g/l

0.4

0.27

122

240

(3028192) IgG subclass 2 [Mass/volume] in Serum

241

324

7.77

169.65

1.9

1.2

g/l

3.2

3.1

0.45

124

241

(3020682) Albumin/Creatinine [Ratio] in Urine

2268

13408

2.28

168.62

5.2

4.0

mg/mmol

17.3

9.2

5.30

1578

8735

(4062490)

241

328

7.67

167.83

1.9

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

327

611

5.66

167.40

1.1

iu/ml

57.0

983.8

0.51

137

(3015377) Calcium [Moles/volume] in Serum or Plasma

2209

12966

2.27

166.53

5.7

3.5

mmol/l

2.3

2.4

25.61

2012

11291

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1152

5055

2.67

166.30

2.8

1.8

1.5

16.62

975

4414

(3012516) Albumin [Mass/volume] in Urine

2167

12746

2.25

161.07

4.2

3.2

mg/l

278.7

382.2

0.69

1554

8338

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1733

9453

2.28

152.92

3.8

2.4

—

(3003396) Base excess in Arterial blood by calculation

1109

4978

2.58

151.30

12.2

7.4

mmol/l

0.6

1.0

1.87

921

3885

(3027801) Oxygen [Partial pressure] in Arterial blood

1107

4992

2.57

149.38

12.2

7.4

kpa

12.5

12.4

0.52

1067

4765

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1107

4994

2.57

149.24

12.3

7.4

kpa

5.0

5.1

1.13

1065

4767

(3002582) Erythrocytes [#/volume] in Urine

2069

12235

2.19

148.54

4.4

3.2

e6/l

60.3

80.7

0.46

1718

9411

(3026782) Osmolality of Urine

1503

7824

2.32

147.19

3.6

2.7

mosm/kgh2o

501.8

565.0

22.19

1337

6646

(3016502) Oxygen saturation in Arterial blood

1026

4498

2.62

146.49

12.8

7.8

95.9

95.5

1.03

999

4325

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

701

2531

3.06

144.45

10.0

7.5

mmol/l

24.5

24.8

0.97

696

2512

(40768797) Stomach Pathology biopsy report

1131

5234

2.50

143.88

1.5

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

963

4130

2.65

143.51

13.3

8.2

g/l

116.3

122.9

17.49

938

3977

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3577

26389

2.28

143.27

7.0

3.0

u/l

122.5

49.9

56.23

3405

24490

(3005719) IgG [Mass/volume] in Serum or Plasma

747

2828

2.93

141.26

2.5

2.7

g/l

10.7

10.6

0.25

630

2598

(3031040) Bacteria [#/volume] in Urine by Automated count

3420

24922

2.21

138.98

5.9

4.2

e6/l

1146.9

1770.7

0.38

342

(3030467) Casts [#/volume] in Urine by Automated count

1915

11217

2.15

138.47

4.4

3.2

e6/l

0.5

0.4

0.78

1580

8419

(3024354) Oxygen [Partial pressure] in Venous blood

788

3123

2.81

136.55

5.2

3.2

kpa

4.6

0.01

759

3012

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2354

14975

2.09

136.20

3.2

2.2

nmol/l

69.2

77.0

30.39

2143

13395

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1307

6593

2.34

136.16

2.4

2.1

30.5

29.9

2.50

1266

6414

(42870588) Differential panel, method unspecified - Blood

2198

13692

2.09

133.90

6.9

6.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

587

1997

3.20

133.45

7.2

4.2

mmol/l

23.7

24.1

2.11

529

1793

(3000850) Epithelial cells [#/volume] in Urine

1547

8443

2.21

132.75

3.5

2.6

e6/l

5.6

4.2

3.00

1420

7393

(3007566) Smooth muscle Ab [Titer] in Serum

372

944

4.18

131.28

1.2

titre

91.3

105.5

0.27

(36304419) Bacteria [Presence] in Urine

1850

10886

2.12

130.34

4.3

3.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2481

16284

2.05

129.71

2.5

2.0

pmol/l

90.8

94.6

3.35

1512

8621

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2351

15192

2.04

127.70

3.8

2.7

ug/l

178.2

164.4

1.06

2189

13989

(3019309) Folate [Moles/volume] in Red Blood Cells

1388

7347

2.24

127.66

2.0

1.7

nmol/l

1237.8

1156.0

2.36

1127

5492

(3018095) Leukocytes [#/volume] in Urine

2211

13995

2.05

126.97

5.1

3.7

e6/l

74.9

86.2

0.27

1780

10093

(3022096) Basophils/100 leukocytes in Blood

2655

18017

2.02

124.66

7.3

6.2

0.7

0.54

2532

16790

(3019069) Monocytes/100 leukocytes in Blood

2721

18631

2.02

124.50

7.5

6.5

8.8

8.9

0.81

2598

17417

(3006315) Basophils [#/volume] in Blood

2847

19860

2.02

122.97

7.3

5.9

e9/l

0.0

3.86

2485

17082

(3006504) Eosinophils/100 leukocytes in Blood

2701

18535

2.01

121.76

7.3

6.2

2.7

2.9

3.57

2572

17274

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

964

4448

2.45

121.32

2.1

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1333

7075

2.21

120.77

5.6

3.2

mmol/l

2.5

2.4

4.40

1196

6204

(3001604) Monocytes [#/volume] in Blood

2829

19772

2.01

120.55

7.3

5.9

e9/l

0.6

10.06

2463

16977

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

963

4465

2.44

119.76

2.1

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

2885

20333

2.00

119.64

7.4

6.0

e9/l

1.8

1.9

2.44

2547

17807

(3034770) Mitochondria Ab [Titer] in Serum

352

924

4.02

118.41

1.2

titre

250.0

980.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

2750

19112

1.99

118.13

7.4

6.2

25.0

27.4

23.28

2617

17765

(3021960) Folate [Moles/volume] in Serum or Plasma

1595

9157

2.09

117.42

1.9

1.5

nmol/l

21.2

20.1

2.28

1437

7832

(3018010) Neutrophils/100 leukocytes in Blood

2717

18833

1.98

117.27

7.2

6.0

59.2

57.4

11.81

2597

17599

(3013115) Eosinophils [#/volume] in Blood

2896

20535

1.99

116.83

7.7

6.2

e9/l

0.2

1.76

2544

17943

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

610

2286

2.90

116.33

1.7

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

159

217

7.54

110.20

1.4

1.3

nmol/l

0.8

1.2

4.73

123

164

(3026008) Bacteria identified in Urine by Culture

1710

10302

2.01

108.48

3.6

3.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1241

6645

2.16

108.27

1.6

1.5

g/l

3.1

2.6

7.99

777

4063

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

609

2393

2.76

105.77

15.2

10.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

965

4737

2.29

103.89

2.5

1.9

1.8

2.62

879

4176

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1311

7301

2.08

102.32

1.4

1.2

u/ml

1.9

2.1

0.21

323

1918

(3036481) Cortisol [Moles/volume] in Serum or Plasma

751

3386

2.44

97.78

2.4

2.3

nmol/l

382.5

369.0

0.89

702

3113

(40758558) Short blood count panel - Blood

1619

9970

1.93

93.36

11.5

7.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

920

4655

2.20

90.83

2.1

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

805

3873

2.29

89.78

1.8

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

264

698

3.94

87.57

1.9

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

815

4008

2.24

85.92

2.4

2.3

ug/g

175.6

149.2

1.08

671

3148

(3037467) Urinalysis macro (dipstick) panel - Urine

3393

26740

1.86

84.74

5.5

4.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

154

268

5.90

84.57

1.3

mmol/l

11.8

12.0

0.15

125

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

553

2316

2.56

83.64

14.9

9.7

mmol/l

23.7

24.3

2.54

529

2175

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

835

4201

2.19

82.97

1.7

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

622

2779

2.42

81.76

5.6

4.3

ng/l

115.3

95.6

2.98

535

2405

(3028026) IgM [Mass/volume] in Serum or Plasma

532

2229

2.55

80.26

1.6

1.9

g/l

1.2

1.4

1.46

491

2025

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2219

15599

1.77

79.96

5.2

3.5

ng/l

49.7

82.2

0.45

1781

11145

(3012501) Base excess in Blood by calculation

302

929

3.40

79.88

6.0

4.3

mmol/l

2.8

2.6

0.92

229

629

(3013290) Carbon dioxide [Partial pressure] in Blood

302

930

3.39

79.74

6.0

4.3

kpa

5.1

5.0

0.24

297

910

(3027315) Oxygen [Partial pressure] in Blood

302

935

3.37

79.05

6.0

4.4

kpa

9.2

8.4

6.50

297

914

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1189

6917

1.95

79.05

3.6

2.8

e6/l

1.2

1.0

0.94

733

3984

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

334

1106

3.17

78.30

1.4

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1125

6450

1.96

77.93

3.7

3.0

e6/l

2.1

1.6

1.17

668

3541

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

815

4159

2.15

77.69

5.6

3.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

577

2553

2.43

77.29

4.9

3.4

g/l

123.7

130.2

8.78

562

2493

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

544

2350

2.48

76.77

1.9

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

349

1202

3.05

76.45

2.2

1.8

—

(3019060) Gas panel - Arterial blood

623

2891

2.32

74.77

8.2

4.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

402

1516

2.80

74.62

6.6

4.0

mmol/l

1.5

1.4

0.41

396

1494

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

475

1950

2.59

74.55

1.8

1.7

g/l

1.5

0.20

422

1671

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1314

8029

1.87

74.50

4.8

3.8

ng/l

222.3

652.0

2.73

1072

6571

(3020191) Ethanol [Moles/volume] in Serum or Plasma

166

355

4.80

72.42

2.5

1.3

promille

1.8

1.3

2.47

123

280

(3023520) Reticulocytes [#/volume] in Blood

718

3580

2.18

72.23

2.6

e9/l

69.4

70.0

0.17

532

2720

(3010421) pH of Blood

323

1099

3.07

72.20

6.0

4.3

7.4

0.48

297

911

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

392

1504

2.74

70.30

3.0

u/ml

0.3

2.55

206

859

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

328

1152

2.98

69.29

2.6

g/l

3.7

3.6

0.20

316

1101

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1845

12691

1.72

68.82

2.7

2.2

u/l

235.9

242.7

0.10

1725

11916

(3020891) Body temperature

425

1721

2.61

68.43

8.1

4.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

894

4954

1.98

67.26

3.2

4.5

u/l

233.3

242.3

0.86

854

4682

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

425

1743

2.57

66.61

2.4

1.9

ug/l

3.0

2.5

0.27

398

1543

(3008152) Bicarbonate [Moles/volume] in Arterial blood

579

2736

2.26

66.16

12.2

7.0

mmol/l

24.2

24.6

1.52

550

2547

(3021589) Normoblasts [#/volume] in Blood

2374

17610

1.67

65.75

17.3

9.6

e9/l

0.0

0.42

1984

14371

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

450

1916

2.48

65.13

4.9

2.7

0.7

0.6

1.91

440

1828

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

382

1535

2.61

62.33

2.4

ug/l

639.3

610.4

0.05

365

1449

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

642

3244

2.13

61.81

6.6

4.0

mmol/l

1.2

5.22

606

2851

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1300

8362

1.75

59.96

1.9

1.7

pmol/l

475.6

30257716.4

5.98

1098

6957

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

159

6.33

58.94

2.6

2.3

umol/l

97.1

152.2

1.00

(3003181) Sodium [Moles/volume] in Urine

223

688

3.35

58.54

1.6

1.3

mmol/l

57.9

63.1

0.87

171

553

(3025941) Bacteria identified in Stool by Culture

443

1967

2.38

58.25

1.4

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

199

583

3.51

56.64

6.9

6.3

mg/l

12.0

11.5

0.86

185

535

(3028707) Methadone [Presence] in Urine by Screen method

169

449

3.86

55.55

2.8

2.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

187

539

3.57

54.56

1.2

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

398

1747

2.39

53.58

8.9

5.1

1.9

1.7

2.28

376

1624

(3027273) Bicarbonate [Moles/volume] in Venous blood

435

1994

2.30

52.99

5.2

3.4

mmol/l

24.8

25.2

1.75

421

1930

(3037522) Nuclear Ab [Titer] in Serum

833

4852

1.86

52.72

1.3

titre

346.8

486.9

2.16

155

935

(4035726)

655

3548

1.98

51.56

1.5

1.4

—

(1616796) Gas panel - Central venous blood

252

906

2.88

50.85

4.7

3.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

388

1723

2.36

50.82

8.8

5.2

0.9

0.33

367

1606

(3020717) Zinc [Moles/volume] in Serum or Plasma

167

5.72

50.52

2.2

1.3

umol/l

21.8

25.7

0.53

159

(3023487) Leukocytes [#/volume] in Peritoneal fluid

144

6.13

50.28

2.0

2.2

e6/l

6217.5

5938.7

0.01

103

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

535

2719

2.08

50.20

4.8

3.6

kpa

5.1

0.32

494

2519

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

404

1837

2.31

50.08

5.7

4.0

50.0

49.3

0.21

396

1813

(3009343) pH of Capillary blood

529

2683

2.09

49.90

4.8

3.6

7.4

1.27

316

(3024928) Oxygen saturation in Venous blood

252

918

2.84

49.62

4.4

3.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

171

5.58

49.27

2.4

2.1

102.6

94.6

1.00

163

(3010370) Gastrin [Moles/volume] in Serum or Plasma

10.95

47.73

2.1

1.8

pmol/l

46.2

43.8

0.05

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

507

2583

2.07

47.14

4.7

3.6

mmol/l

1.3

1.7

1.23

374

1919

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

140

367

3.90

46.90

1.2

u/l

56.2

65.6

1.00

245

(3022217) INR in Platelet poor plasma by Coagulation assay

903

5582

1.76

46.31

18.0

25.1

inr

1.2

1.4

2.95

126

787

(3013707) Erythrocyte sedimentation rate by Westergren method

3440

29189

1.59

46.30

4.9

3.9

mm/h

16.4

11.9

38.95

3193

27028

(3000494) Fungus identified in Specimen by Culture

793

4722

1.81

46.19

2.2

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

862

5274

1.77

45.77

2.0

1.7

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

18.12

44.68

2.0

1.3

u/l

3249.9

3050.9

0.02

(3035350) Ketones [Presence] in Urine by Test strip

2390

18813

1.52

44.58

4.6

3.4

estimate

0.0

0.80

566

3375

(3011288) Drugs identified in Urine by Screen method

195

658

3.04

44.05

3.2

2.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

294

1238

2.46

43.22

2.3

81.9

90.2

6.37

286

1168

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

271

1100

2.55

43.07

2.4

2.6

226.8

193.0

5.49

252

1048

(3017181) Myelocytes/100 leukocytes in Blood

603

3389

1.89

42.01

3.4

4.2

1.0

0.9

0.29

226

1001

(3021601) Nitrite [Presence] in Urine by Test strip

2373

18834

1.50

41.36

6.0

4.6

estimate

0.0

0.80

575

3465

(3047181) Lactate [Moles/volume] in Blood

306

1349

2.35

40.59

10.2

6.0

mmol/l

1.6

1.3

5.42

266

1187

(3009261) Glucose [Presence] in Urine by Test strip

2390

19052

1.49

40.42

4.6

3.5

estimate

0.0

1.74

519

3306

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

270

1129

2.47

40.27

4.7

3.0

mg/l

1.8

1.6

3.87

245

1033

(3051651) Icteric interference index of Serum or Plasma

101

234

4.39

39.95

5.4

3.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

607

3477

1.85

39.71

2.1

2.6

g/l

65.3

66.6

3.23

561

3167

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

160

511

3.20

39.69

1.1

g/l

1.6

1.5

2.67

144

462

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1205

8322

1.59

39.51

1.9

1.8

mg/l

1.6

1.3

2.03

962

6405

(40767503) Oxygen content in Capillary blood by calculation

230

901

2.63

39.30

3.1

2.4

15.3

16.5

3.24

110

462

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

257

1063

2.50

39.23

2.4

ug/min

218.6

108.0

1.71

154

672

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

178

610

2.99

39.14

1.1

—

(3033799) Differential panel - Peritoneal fluid

131

5.64

38.86

1.7

2.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

234

930

2.59

38.82

4.5

2.9

kpa

8.1

8.0

0.31

214

856

(3052851) Hemolysis interference index of Serum or Plasma

272

1162

2.42

38.70

5.3

3.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

154

5.20

38.43

3.0

2.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

7.57

38.17

2.1

5.1

u/l

256.1

41.0

0.97

(3016650) Hepatitis A virus Ab [Presence] in Serum

174

598

2.98

38.07

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

248

1025

2.49

37.91

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

133

5.48

37.16

1.9

2.0

e6/l

11551.1

18224.0

0.16

(3002179) Metamyelocytes/100 leukocytes in Blood

544

3087

1.86

36.52

3.4

4.0

0.6

0.12

167

719

(3036489) Thrombin time

318

1489

2.21

36.52

2.2

2.1

22.7

21.6

1.17

284

1318

(1001926) Buprenorphine [Presence] in Urine by Screen method

207

798

2.66

36.52

2.8

2.1

—

(40761536) Microorganisms panel - Urine sediment

551

3140

1.85

36.49

5.5

3.8

—

(3044007) Cell count panel - Peritoneal fluid

118

5.74

36.38

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

233

4.18

35.77

1.1

—

(3022145) Colonoscopy Study observation

707

4370

1.72

35.45

1.4

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

224

4.21

35.01

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

224

4.21

35.01

1.1

1.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1596

11977

1.49

34.92

3.0

3.1

ng/l

1845.9

1443.2

2.01

1400

10282

(3021440) Promyelocytes/100 leukocytes in Blood

555

3223

1.81

34.48

3.6

4.2

0.1

0.03

206

930

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

245

4.02

34.27

1.3

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

461

2551

1.89

33.37

1.6

1.4

—

(36660697) Celiac disease serology panel - Serum

472

2634

1.88

33.28

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

204

821

2.55

32.98

7.3

5.7

iu/ml

768.9

636.5

0.09

124

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4343

40000

1.70

32.20

36.3

14.1

mg/l

33.0

25.1

37.12

4009

31598

(3018572) Chloride [Moles/volume] in Blood

228

980

2.39

31.98

12.2

6.8

mmol/l

104.3

105.1

1.30

211

870

(3039000) Anion gap in Blood

228

980

2.39

31.98

12.2

6.8

mmol/l

11.7

11.4

0.70

211

870

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

202

828

2.50

31.42

1.4

—

(3025159) Blasts/100 leukocytes in Blood

519

3035

1.79

31.38

3.6

4.2

0.0

0.3

0.93

175

777

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

231

1014

2.34

30.90

1.4

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1180

8504

1.51

30.70

5.2

4.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

231

1023

2.32

30.27

1.4

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1367

10181

1.47

30.13

5.2

3.9

estimate

0.0

0.34

527

3268

(3002256) Pathology report gross observation

739

4808

1.63

30.10

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

614

3816

1.70

29.85

2.9

2.3

ug/l

4.4

8.9

15.44

532

3394

(3004588) Protein electrophoresis panel - Serum or Plasma

494

2890

1.79

29.76

2.0

2.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

229

1020

2.31

29.61

1.9

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

231

1033

2.30

29.59

1.4

1.2

—

(3022313) Gas panel - Capillary blood

369

1979

1.93

29.27

5.2

3.7

—

(3016879) Cocaine [Presence] in Urine

221

975

2.33

29.22

2.8

2.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

223

988

2.32

29.20

1.8

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

239

1094

2.24

28.97

3.5

3.2

mmol/l

24.3

24.8

1.01

208

946

(3026250) Tacrolimus [Mass/volume] in Blood

174

4.30

28.79

43.5

35.1

ug/l

7.3

7.5

0.22

162

(40768441) Liver Pathology biopsy report

251

3.67

28.44

1.5

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

272

1321

2.12

28.42

7.4

4.3

mmol/l

3.9

0.62

258

1247

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

157

598

2.68

28.40

2.2

1.9

ug/l

16.1

25.4

3.11

152

590

(40768804) Tissue Pathology biopsy report

1937

15516

1.41

28.28

2.5

2.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

10.77

27.76

1.2

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

640

2.60

27.75

3.7

2.7

u/ml

270.8

2715.5

—

(4198724)

138

4.69

27.74

2.1

1.6

—

(3013512) EKG study

1549

11961

1.43

27.69

4.9

3.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

192

823

2.39

27.11

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

192

823

2.39

27.11

1.4

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

233

1088

2.20

26.90

1.8

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

226

1044

2.22

26.79

2.8

2.1

—

(3028300) Cannabinoids [Presence] in Urine

227

1051

2.22

26.76

2.8

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

119

404

2.99

26.68

5.4

3.1

—

(3042517) Benzodiazepines panel - Urine

11.26

26.67

2.3

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

195

850

2.35

26.52

1.6

1.7

—

(3021901) Oxygen saturation in Capillary blood

182

770

2.42

26.46

3.2

2.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

164

663

2.52

26.30

1.4

1.2

u/ml

310.0

290.3

0.35

107

411

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

233

1100

2.17

26.17

1.4

1.3

iu/ml

5.2

22.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

166

682

2.48

25.73

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

212

3.77

25.72

1.6

u/l

4.8

6.1

0.28

104

(3011397) Hemoglobin [Presence] in Urine by Test strip

1202

8980

1.45

25.28

4.2

3.5

—

(3027008) Opiates [Presence] in Urine

223

1049

2.18

25.28

2.7

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

178

763

2.38

25.15

1.7

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

210

968

2.22

25.03

1.9

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

313

1679

1.92

24.76

2.3

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

169

713

2.42

24.74

1.4

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

160

4.17

24.71

1.9

1.8

umol/l

30.6

7.2

1.34

100

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

163

679

2.45

24.54

1.7

1.5

u/ml

111.3

113.5

0.09

143

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.58

24.40

2.1

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

200

917

2.23

24.16

1.2

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

260

1319

2.03

24.16

2.8

3.5

ratio

2.2

3.8

0.58

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

127

473

2.73

24.04

1.4

1.3

nmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

164

3552

0.44

23.91

1.8

—

(3027944) Amphetamines [Presence] in Urine

216

1027

2.15

23.84

2.8

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.68

23.78

1.4

2.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

290

1539

1.94

23.68

2.2

1.8

—

(21494755) Public health laboratory ask at order entry panel

172

3640

0.45

23.56

1.3

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

262

1350

1.99

23.30

2.8

3.5

mg/l

44.7

55.1

0.47

207

1090

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

219

3.56

23.05

1.3

1.2

u/l

134.7

84.5

2.24

186

(3016273) Islet cell 512 Ab [Units/volume] in Serum

12.99

22.84

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

261

1353

1.98

22.82

2.8

3.5

mg/l

96.5

96.9

0.00

205

1090

(1761868) Lipid panel - Serum or Plasma

1117

14513

0.70

22.81

3.6

2.9

—

(3008295) Osmolality of Serum or Plasma

113

408

2.81

22.70

1.5

1.3

mosm/kgh2o

275.1

279.1

0.98

312

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

309

1699

1.87

22.65

5.7

3.8

mmol/l

24.3

24.8

1.86

288

1556

(3042733) HLA Ab [Presence] in Serum

137

4.27

22.49

5.1

5.0

—

(3019225) pH of Specimen

598

3949

1.59

22.48

6.1

4.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

211

3.55

22.09

1.3

1.2

u/l

39.9

22.9

1.21

177

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

174

3.83

22.08

1.1

u/l

41.3

30.3

0.43

133

(3019977) pH of Arterial blood

231

3.41

21.97

3.6

2.5

7.4

0.48

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

7.15

21.60

1.2

2.1

mmol/l

0.9

0.01

(3016038) Potassium [Moles/volume] in Urine

264

3.22

21.53

1.4

1.1

mmol/l

27.1

34.6

2.51

231

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

547

3574

1.60

21.46

2.9

ng/l

224.1

199.8

0.46

502

3252

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

173

3.79

21.46

1.1

1.2

u/l

119.4

97.4

0.56

136

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

261

1384

1.94

21.36

1.6

1.5

titre

120.0

337.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

281

1528

1.89

21.32

2.9

2.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

171

775

2.25

21.27

3.9

3.7

58.4

57.4

0.51

171

775

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

133

543

2.49

20.95

1.5

1.3

nmol/l

0.6

0.16

123

519

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

166

749

2.26

20.87

1.9

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

190

911

2.13

20.55

2.5

2.1

g/l

122.3

132.0

5.54

138

645

(40760888) Immunoglobulin light chains.free panel - Serum

205

1012

2.07

20.54

2.9

3.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

109

408

2.71

20.48

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1776

14560

1.34

20.46

5.0

3.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

128

525

2.48

19.98

1.6

1.4

e6/l

9590.0

2264.6

0.50

375

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

199

982

2.07

19.96

1.4

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

282

1570

1.84

19.87

1.4

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3200

28619

1.33

19.80

4.2

3.6

pmol/l

14.7

14.9

1.46

2897

25871

(40768446) Kidney Pathology biopsy report

165

3.73

19.71

2.0

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

130

542

2.44

19.60

1.5

1.3

nmol/l

0.2

0.3

0.83

(3003434) Protein [Mass/volume] in Pleural fluid

138

592

2.37

19.53

1.5

1.4

g/l

30.2

33.5

2.07

126

530

(3005988) Vibrio sp identified in Specimen by Organism specific culture

120

484

2.52

19.42

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

177

3.59

19.26

1.2

6.8

mg/l

57.4

1490.2

0.50

117

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

293

2.97

19.26

1.1

titre

100.0

130.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

119

482

2.51

19.09

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4069

37862

1.42

19.04

9.7

5.8

mmol/mol

46.7

40.1

163.23

3833

35054

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

120

489

2.49

19.01

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

751

2.18

18.70

1.9

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

118

481

2.49

18.69

1.5

—

(3045788) Cell count panel - Pleural fluid

104

399

2.64

18.66

1.6

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

161

752

2.18

18.64

3.6

3.4

e9/l

4.5

4.1

1.07

161

752

(3028308) Erythrocytes [#/volume] in Pleural fluid

117

476

2.49

18.61

1.6

1.4

e6/l

25200.9

72170.4

1.66

273

(3023419) Bacteria identified in Sputum by Culture

128

543

2.39

18.59

6.3

2.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

137

600

2.32

18.51

1.9

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

112

4.23

18.07

1.6

1.5

g/l

10.5

14.5

2.11

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

326

2.79

18.05

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

205

3.30

17.99

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

237

3.11

17.79

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

119

499

2.42

17.75

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

203

3.28

17.58

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

193

990

1.99

17.43

1.4

1.2

—

(3012565) Volume of 24 hour Urine

205

3.25

17.31

2.3

2.4

1824.9

1956.3

0.40

179

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

266

1524

1.79

17.07

1.9

2.4

g/l

10.2

0.01

225

1289

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

116

490

2.40

17.04

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

4.49

17.02

1.3

g/l

20.7

27.7

1.53

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

124

541

2.33

16.93

1.8

2.3

31.6

32.8

1.81

124

536

(3035637) Corticotropin [Mass/volume] in Plasma

112

468

2.43

16.85

1.6

1.5

—

(4146454)

110

456

2.44

16.84

3.3

2.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

116

493

2.39

16.81

1.5

—

(44790049)

114

481

2.40

16.79

1.8

1.4

—

(44806118)

114

481

2.40

16.79

1.8

1.4

—

(44790048)

114

481

2.40

16.79

1.8

1.4

—

(44790047)

114

481

2.40

16.79

1.8

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1343

10811

1.33

16.75

1.5

1.3

—

(3004775) Volume in Urine collected for unspecified duration

351

2.65

16.73

2.1

2.2

792.2

643.3

2.33

242

(3030981) Hyaline casts [#/volume] in Urine by Automated count

346

2149

1.66

16.58

3.1

2.8

e6/l

0.4

0.2

0.69

339

2100

(3026493) Urate [Moles/volume] in Serum or Plasma

1409

11450

1.32

16.38

3.1

2.7

umol/l

3425.4

4874.7

0.75

1231

9952

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

113

481

2.38

16.33

2.0

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

282

2.83

16.32

1.1

mg/l

279.1

282.7

0.14

251

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

204

1092

1.91

16.27

1.4

1.5

g/l

0.2

0.01

191

1036

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

102

2280

0.44

16.03

1.4

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

500

3419

1.51

15.84

3.9

2.7

ml/min/173m2

66.1

65.7

0.06

211

1327

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

263

1536

1.75

15.81

1.9

2.4

g/l

3.2

3.1

0.74

214

1204

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

276

1635

1.73

15.78

1.9

2.4

g/l

3.9

3.8

0.79

213

1182

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

276

1637

1.73

15.71

1.9

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

276

1638

1.73

15.68

1.9

2.4

g/l

7.4

0.06

216

1231

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1276

1.82

15.54

1.9

2.3

g/l

35.3

37.8

5.61

200

1105

(3004451) EKG impression Narrative

214

3.06

15.52

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

209

1150

1.85

15.33

2.0

2.4

g/l

0.0

0.50

191

1053

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

207

1137

1.86

15.26

1.4

1.5

g/l

1.2

0.51

194

1080

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.34

15.19

1.2

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

206

1132

1.86

15.17

2.0

2.4

g/l

0.0

0.00

190

1052

(3012441) Differential panel - Pleural fluid

108

467

2.34

15.10

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

103

437

2.39

15.03

73.4

5.8

mmol/l

8.8

7.3

3.02

365

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

257

2.83

14.91

1.3

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

137

659

2.11

14.79

1.6

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

225

1281

1.79

14.77

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1242

10052

1.31

14.54

4.5

3.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

218

1237

1.80

14.48

1.9

2.3

g/l

0.0

0.31

200

1137

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

101

434

2.35

14.34

6.2

3.8

—

(3016750) Collection duration of Urine

253

2.79

14.18

1.9

2.1

min

518.2

488.8

1.20

190

(3044889) 12 lead EKG panel

3214

29317

1.27

14.17

4.9

3.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

196

3.03

13.91

3.8

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

137

677

2.05

13.79

4.9

3.3

—

(3037756) Immunofixation for Serum or Plasma

164

864

1.93

13.77

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

237

1405

1.72

13.54

2.0

2.5

g/l

0.3

1.0

6.47

207

1213

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

254

2.74

13.52

1.3

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

603

2.10

13.43

1.9

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.71

13.28

6.5

5.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

116

3.64

13.26

1.2

—

(3011985) Renin [Units/volume] in Plasma

115

540

2.16

13.24

1.4

mu/l

50.1

57.1

0.24

480

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

5.74

13.19

4.4

3.7

mg/l

1.5

0.9

0.61

(3036782) Glucose [Moles/volume] in Pleural fluid

401

2.34

13.14

1.4

mmol/l

7.2

6.3

1.39

367

(3042631) Mycobacterium sp identified in Specimen

124

604

2.08

13.00

3.3

2.7

—

(3037121) Protein [Mass/volume] in Urine

236

1415

1.70

12.95

3.6

3.3

g/l

0.5

0.3

1.30

130

660

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1325

10958

1.29

12.91

1.8

1.7

mmol/l

1.6

1.4

3.00

1157

9174

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

314

2026

1.59

12.89

2.3

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4392

41984

1.41

12.78

41.7

16.4

mmol/l

138.3

139.7

170.61

4326

40947

(3010375) cycloSPORINE [Mass/volume] in Blood

181

3.01

12.57

27.3

25.9

ug/l

108.7

114.6

0.27

153

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

116

3.56

12.51

1.5

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

337

2.43

12.41

2.0

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

120

589

2.06

12.34

1.7

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

3540

32928

1.26

11.94

41.1

17.3

14.2

13.7

78.01

3499

32195

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3796

35636

1.28

11.70

5.3

4.3

mu/l

2.0

2.3

1.29

3472

32380

(3004809) Band form neutrophils/100 leukocytes in Blood

135

705

1.94

11.69

2.1

3.5

1.3

1.6

0.63

105

525

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

225

2.69

11.41

2.7

2.0

ug/min

89.4

214.4

0.60

(40768806) Pleura Pathology biopsy report

100

474

2.13

11.30

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4392

42127

1.38

11.22

41.7

16.6

mmol/l

4.0

0.72

4322

41038

(3019150) Specific gravity of Urine by Refractometry

1014

8255

1.29

10.91

4.8

3.9

kg/l

1.0

0.62

147

1191

(4281824)

333

2.33

10.87

1.4

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

250

1594

1.60

10.82

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.89

10.82

2.0

2.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

237

1494

1.62

10.75

1.1

titre

319.0

257.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

424

2.14

10.37

1.6

1.9

—

(3017569) Oxygen content in Arterial blood

202

2.69

10.35

4.2

2.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

165

956

1.75

10.30

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

342

2.27

10.25

1.7

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

455

2.09

10.11

1.7

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

442

2.10

10.09

2.1

4.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

234

2.54

10.07

1.4

1.5

—

(3024932) HLA-DR beta [Type]

140

3.02

9.94

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

152

870

1.77

9.91

1.1

u/ml

2.5

7.6

1.50

102

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

101

508

2.01

9.80

1.3

pmol/l

287.3

279.1

0.08

384

(3024471) HLA-A [Type]

142

2.97

9.70

1.0

—

(4010399)

398

2880

1.42

9.35

1.6

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

226

2.49

9.25

2.1

2.2

umol/l

80.0

20.9

1.21

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

120

662

1.83

8.88

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

454

2.00

8.71

1.8

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

396

2.06

8.55

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

502

1.93

8.40

3.2

2.1

mmol/l

104.9

105.6

0.58

494

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

202

2.49

8.28

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

202

2.49

8.28

1.4

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.27

8.19

1.1

1.2

pmol/l

347.7

245.8

0.46

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

357

2.09

8.11

1.1

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

502

1.91

8.07

3.2

2.1

mmol/l

4.1

0.47

494

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

267

2.26

8.04

1.3

1.4

umol/l

13.1

13.5

0.15

249

(40761539) Cells [Type] in Urine sediment by Light microscopy

104

3.09

7.96

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

201

1317

1.55

7.82

1.3

1.2

u/ml

0.7

1.0

0.22

122

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

378

2.03

7.70

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

378

2.03

7.70

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

378

2.03

7.70

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

366

2.04

7.61

2.3

2.4

—

(3035880) pH of Pleural fluid

237

2.29

7.49

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

459

1.91

7.46

2.2

2.4

u/l

5452.7

3475.3

0.20

163

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

244

1689

1.47

7.32

1.6

1.8

u/l

43.9

38.6

2.88

222

1476

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

448

1.91

7.32

1.1

—

(3045716) Anion gap in Serum or Plasma

191

2.42

7.24

3.8

2.7

mmol/l

9.2

9.1

0.04

142

(3026389) Candida sp identified in Specimen by Organism specific culture

458

1.89

7.18

1.6

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1324

0.51

7.16

1.3

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

283

2.13

7.02

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

317

2321

1.39

6.99

1.2

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

2.81

6.99

2.6

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

2.81

6.99

2.6

2.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

337

2493

1.38

6.99

1.8

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

2.56

6.92

2.1

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

119

2.79

6.88

2.0

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

142

2.62

6.86

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1486

16695

0.84

6.84

3.9

4.1

22.2

21.9

0.25

646

7962

(40761535) Cells panel - Urine sediment

437

3381

1.32

6.75

4.2

3.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

198

2.34

6.71

2.1

3.1

—

(3002619) Bacteria identified in Specimen by Culture

3.50

6.70

1.5

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

491

1.83

6.69

3.4

2.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

103

596

1.74

6.60

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

200

2.31

6.57

2.2

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

395

1.91

6.52

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

306

2258

1.38

6.46

1.8

—

(3006270) Folate [Moles/volume] in Blood

327

2.00

6.44

1.2

nmol/l

367.8

360.1

0.10

275

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

124

2.67

6.39

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1552

0.58

6.34

1.5

1.6

—

(3049717) Cytology report of Urine Cyto stain

249

1780

1.42

6.33

2.6

2.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

119

2.70

6.33

1.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

472

1.81

6.28

2.3

2.0

titre

4914.3

1597.3

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

+∞

6.25

1.7

0.0

umol/l

111.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

199

2842

0.69

6.23

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

206

2.24

6.16

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

206

2.24

6.16

1.2

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

272

2.07

6.12

1.1

—

(3014271) Vancomycin [Susceptibility]

213

2.22

6.12

3.1

2.8

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

12.52

6.07

1.3

mmol/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

384

1.89

6.05

2.1

1.9

g/24h

2.0

1.1

—

(3025315) Body weight

4.30

6.02

3.9

4.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.23

6.00

3.0

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

117

2.66

5.98

1.1

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.79

5.80

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1055

12070

0.84

5.80

2.8

2.9

ug/l

0.7

0.8

3.78

744

7872

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

728

6104

1.23

5.78

1.2

1.3

iu/ml

36.3

35.6

0.03

180

1902

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.01

5.74

1.1

1.4

—

(3044927) Protein electrophoresis panel - Urine

413

1.83

5.73

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

2.81

5.56

1.2

1.3

mu/l

104.4

48.2

0.54

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.73

5.36

2.5

1.9

51.2

53.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

268

2000

1.36

5.32

3.0

3.4

pmol/l

4.2

4.5

4.93

231

1782

(3045683) HLA typing for celiac disease panel - Blood or Tissue

181

2.22

5.27

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

181

2.22

5.27

1.8

1.6

u/field

2.3

2.2

0.07

141

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.01

5.16

2.6

1.7

26.3

18.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

224

2.06

5.06

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3927

40530

0.85

4.96

5.2

4.5

mmol/l

4.2

4.6

94.52

3618

37612

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

169

1183

1.44

4.90

1.7

1.6

iu/ml

0.3

8.2

0.91

264

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

383

1.79

4.88

1.1

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

100

2.61

4.88

3.5

2.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

157

1085

1.46

4.87

1.6

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

183

2.14

4.74

2.6

2.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

253

1913

1.34

4.65

1.7

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.85

4.65

1.0

1.4

—

(40761511) CBC panel - Blood by Automated count

4282

41696

1.20

4.55

32.1

13.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3902

40229

0.86

4.51

5.1

4.5

mmol/l

1.3

1.4

24.17

3562

37117

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

285

1.87

4.44

1.8

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

243

1.94

4.43

1.2

1.4

u/l

5.3

7.0

1.29

207

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

112

739

1.53

4.39

1.1

1.2

—

(3007463) Buprenorphine [Presence] in Urine

7.51

4.35

4.9

7.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1305

0.63

4.27

1.4

1.7

mg/l

5.9

3.3

0.66

928

(3028433) Virus identified in Specimen by Culture

145

2.21

4.26

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2442

22931

1.13

4.26

2.9

2.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

220

1.96

4.19

6.0

3.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

314

1.79

4.14

1.9

2.4

e6/l

701.2

638.9

0.17

133

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.99

4.12

3.8

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3957

38354

1.16

4.10

32.2

13.4

ml/min/173m2

82.5

80.1

8.14

3502

31769

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

252

1.87

4.01

1.9

1.6

—

(3020491) Glucose [Moles/volume] in Blood

288

1.81

4.01

2.0

mmol/l

7.8

6.9

0.87

192

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

111

2.35

3.98

1.4

nmol/l

132.7

136.9

0.04

(3001893) Eosinophils/100 leukocytes in Pleural fluid

143

2.18

3.98

1.4

2.9

0.00

123

(3017732) Neutrophils [#/volume] in Blood

341

2745

1.26

3.96

3.8

3.0

e9/l

4.4

4.1

0.80

251

2117

(1002224) Polysomnography panel

123

1755

0.69

3.94

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

268

1.84

3.94

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

254

1.86

3.92

1.9

1.6

—

(3022621) pH of Urine by Test strip

309

2461

1.27

3.92

3.2

2.8

—

(40757373) Influenza virus identified in Isolate

2.57

3.88

2.4

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4023

41287

0.86

3.87

5.8

5.0

mmol/l

2.4

2.7

126.21

3694

38097

(1761482) Bacteria [#/volume] in Urine by Culture

138

976

1.43

3.87

5.3

3.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.78

3.85

1.0

1.2

umol/24h

0.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

452

1.62

3.80

2.1

3.7

58.5

58.0

0.08

271

(3025549) Creatine [Moles/time] in 24 hour Urine

3.80

1.1

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

414

1.65

3.79

3.5

3.0

mg/l

60.5

65.4

0.05

310

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

215

1.91

3.76

2.1

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

215

1.91

3.76

2.1

2.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

215

1.91

3.76

2.1

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

215

1.91

3.76

2.1

2.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.73

3.75

1.4

1.2

mmol/l

0.7

1.6

0.59

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

122

2.22

3.66

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.79

3.55

2.0

1.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.79

3.55

2.0

2.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.40

3.55

1.1

1.2

90.3

95.1

0.13

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

124

2.18

3.53

1.3

1.2

ug/l

84.7

194.6

0.47

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

125

885

1.42

3.52

1.1

1.3

mmol/l

4.5

3.8

5.98

118

827

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

158

2.03

3.49

1.8

1.6

nmol/l

2.5

6.3

0.78

139

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

112

2.24

3.47

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.51

3.37

1.3

1.5

—

(3000492) Spirometry study

468

3970

1.20

3.32

1.6

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

211

1.86

3.30

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

446

1.58

3.29

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

252

2005

1.27

3.27

1.2

iu/ml

114.9

139.2

0.48

724

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.34

3.24

1.0

1.3

78.7

82.0

0.13

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.16

3.21

2.9

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

199

1.87

3.19

1.9

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

157

1.98

3.18

2.5

2.3

—

(3038026) Centromere Ab [Units/volume] in Serum

295

1.70

3.18

1.2

—

60.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

597

5192

1.17

3.17

13.4

6.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.96

3.13

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

274

1.72

3.13

2.2

1.9

u/field

2.0

1.7

0.17

113

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.63

3.13

1.6

1.7

ng/l

120.3

173.6

0.78

(3005322) IgE [Units/volume] in Serum or Plasma

270

2180

1.25

3.11

1.6

1.3

u/ml

377.3

248.3

0.62

260

1996

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.51

3.11

1.0

1.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

142

1052

1.36

3.10

1.7

1.9

mg/l

10.8

11.3

0.20

134

981

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

166

1.93

3.08

1.8

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

166

1.93

3.08

1.8

2.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

125

2.09

3.07

1.2

1.3

g/l

0.3

1.67

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

7.51

3.05

1.0

u/field

1.2

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.01

3.05

1.1

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

481

1.53

3.00

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

168

1.91

2.99

1.8

2.5

—

(40768443) Skin Pathology biopsy report

221

1754

1.27

2.96

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

105

746

1.42

2.96

1.2

—

29.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

556

1.48

2.95

1.1

111.9

114.3

0.31

499

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

654

5761

1.16

2.94

1.2

u/ml

5.7

12.2

2.13

212

2181

(3017704) Immunofixation for Urine

220

1.78

2.92

1.6

—

(4306422)

574

1.47

2.91

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

366

1.59

2.88

1.3

1.2

—

(3022475) Manganese [Moles/volume] in Blood

4.10

2.88

1.1

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.39

2.87

1.4

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

6.67

2.86

1.3

umol/l

5590.0

5231.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.25

2.86

1.7

2.4

mmol/l

6.8

8.6

0.87

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.93

2.85

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

118

862

1.38

2.84

1.3

1.2

u/ml

3.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

596

1.45

2.79

1.2

u/ml

3.2

2.9

0.04

188

(40768800) Prostate Pathology biopsy report

1279

0.71

2.78

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

247

1.71

2.75

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

119

876

1.37

2.74

1.3

1.2

u/ml

13.9

7.3

0.25

135

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.31

2.74

1.4

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.20

2.73

1.1

69.3

86.1

1.29

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.01

2.72

1.3

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

127

947

1.35

2.71

2.0

1.7

mu/l

375.5

287.3

1.06

117

882

(3000475) Leukocytes [#/volume] in Synovial fluid

134

1008

1.34

2.70

1.6

e6/l

19328.0

15888.2

0.29

721

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

146

1.92

2.69

3.0

1.9

u/ml

610.0

2803.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.75

2.67

1.2

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

635

1.43

2.67

5.6

5.1

umol/l

368.3

357.3

0.26

547

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.18

2.66

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.13

2.64

1.0

1.2

umol/24h

1.3

1.8

—

(3000330) Specific gravity of Urine by Test strip

239

1943

1.24

2.64

4.3

3.3

—

(3000012) Reticulocyte production index

220

1.73

2.64

1.4

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

399

1.54

2.63

1.3

1.4

e6/l

126484.1

82377.8

0.29

281

(3043410) Blood group antigens tested for on Red Blood Cells

106

2.08

2.62

1.8

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

579

1.44

2.62

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

103

747

1.39

2.62

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

119

884

1.35

2.61

1.2

1.5

e6/l

215.9

1150.1

2.73

721

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

282

1.64

2.60

1.6

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

124

929

1.34

2.58

1.3

1.2

u/ml

3.9

32.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

200

1.76

2.55

1.2

ratio

1.1

1.0

0.55

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

307

1.60

2.55

1.3

1.4

u/l

28.5

24.9

0.28

249

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

276

1.64

2.54

1.6

1.5

u/ml

30.4

22.2

—

(3044941) Cell count panel - Synovial fluid

650

1.41

2.54

1.3

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

162

1264

1.29

2.53

2.1

3.7

u/ml

49.6

62.5

0.54

155

1213

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

292

1.62

2.53

1.2

—

36.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.60

2.53

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

101

2.08

2.52

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

179

1.79

2.51

1.3

1.4

48.1

66.7

2.15

147

(3044290) Cell count panel - Cerebral spinal fluid

110

813

1.36

2.51

1.2

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

118

882

1.35

2.50

1.1

1.4

e6/l

20.0

20.2

0.00

683

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

512

1.45

2.46

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

1.69

2.46

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.81

2.46

9.4

5.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

144

1.88

2.45

1.3

1.1

miu/ml

1418.4

1554.5

0.30

144

(1617658) Protocol used for examination of sentinel lymph nodes

221

0.41

2.42

1.1

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.00

2.40

3.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

147

1142

1.30

2.39

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.34

2.39

4.6

1.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

453

0.55

2.39

2.0

2.8

13.6

13.2

0.76

446

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

274

1.61

2.37

1.2

—

3.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

161

1.81

2.34

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1981

20844

0.92

2.33

4.3

4.7

ug/l

3.1

0.00

1762

18837

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

428

1.48

2.31

1.1

88.6

97.4

1.78

399

(3010813) Leukocytes [#/volume] in Blood

4422

44831

0.87

2.29

50.0

20.8

e9/l

7.5

6.7

77.41

4326

43490

(3000963) Hemoglobin [Mass/volume] in Blood

4422

44830

0.87

2.29

50.4

20.9

g/l

127.0

138.0

316.62

4372

44158

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

766

1.35

2.29

1.8

iu/l

89.6

5.0

0.48

261

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.46

2.27

1.0

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.56

2.27

1.1

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.07

2.26

1.2

2.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

406

0.54

2.25

1.3

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

4422

44822

0.87

2.23

50.0

20.8

e12/l

4.2

4.6

267.77

4326

43480

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

131

1013

1.30

2.23

1.2

1.3

mg/l

540.6

545.4

0.04

125

960

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

209

1.68

2.22

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

164

1.77

2.22

1.1

—

(3024731) MCV [Entitic volume]

4422

44818

0.87

2.21

49.8

20.7

91.8

91.3

12.63

4376

44151

(3020393) Adenovirus Ag [Presence] in Stool

2.78

2.20

2.7

1.3

—

(3035941) MCH [Entitic mass]

4422

44815

0.87

2.19

49.7

20.7

30.5

0.45

4375

44150

(3047189) Immunofixation for 24 hour Urine

218

1.66

2.18

1.8

—

(21494434) Karyotype in Bone marrow

385

1.49

2.17

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

2.24

2.17

7.3

6.8

—

(3030313) Adrenal Ab [Titer] in Serum

4.29

2.15

1.5

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

180

0.39

2.15

1.3

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.20

2.09

1.6

1.5

umol/24h

579.5

384.2

—

(3003338) MCHC [Mass/volume]

3322

34126

0.92

2.08

44.7

18.1

g/l

331.9

333.4

17.71

3292

33876

(3022689) Creatine [Moles/volume] in Urine

131

1.84

2.07

2.3

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.26

2.07

1.1

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

482

0.60

2.06

1.1

1.4

pmol/l

178.1

131.7

0.23

146

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

490

1.41

2.05

2.5

2.1

mg/l

23.6

24.0

0.02

122

(3007461) Platelets [#/volume] in Blood

4422

44791

0.88

2.04

50.0

20.8

e9/l

251.1

242.7

10.69

4340

43585

(3038177) Helicobacter pylori Ab [Presence] in Serum

560

1.38

2.00

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

240

1.59

1.98

2.7

1.3

u/ml

2.1

1.6

0.14

117

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.75

1.93

1.0

2.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.12

1.92

1.8

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

188

1.65

1.90

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

172

0.41

1.90

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

173

0.40

1.89

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

114

1.85

1.86

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

1.85

1.86

1.3

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

586

1.35

1.84

1.2

u/ml

4.0

4.1

0.01

262

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.53

1.83

5.7

8.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4383

43230

1.12

1.83

24.3

10.2

u/l

31.3

27.9

19.57

4306

41644

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.76

1.79

1.9

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

128

1020

1.26

1.79

1.3

1.4

u/l

9.8

7.5

1.31

103

821

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.34

1.77

2.3

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

256

1.53

1.75

2.1

2.7

37.3

36.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

1.80

1.74

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

191

0.47

1.72

1.2

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.92

1.72

1.4

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

103

1.85

1.71

1.7

1.4

ug/l

10.9

9.3

0.57

103

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

163

1.66

1.71

1.1

iu/ml

335.1

183.8

0.54

163

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

171

1.64

1.70

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

101

788

1.29

1.69

2.0

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

178

0.45

1.69

1.4

1.5

—

(3021788) Differential panel - Synovial fluid

753

1.29

1.68

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

203

1.58

1.67

1.2

1.6

—

(3048879) Bone marrow aspiration report

126

1.75

1.67

1.2

1.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.18

1.67

1.0

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.18

1.67

1.0

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.18

1.67

1.0

1.4

—

(4015189)

119

1.77

1.65

3.4

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3727

36524

1.08

1.65

36.0

15.2

37.2

40.4

65.34

2421

25970

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.25

1.63

2.2

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

225

0.49

1.62

1.5

—

(4027681)

205

1.56

1.62

1.4

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

210

0.48

1.59

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

210

0.48

1.59

1.5

1.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.95

1.59

1.5

1.1

mmol/l

1.3

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

209

0.48

1.57

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

209

0.48

1.57

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

255

1.49

1.57

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

255

1.49

1.57

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

256

1.49

1.55

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.11

1.55

1.3

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

122

1.72

1.54

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

257

1.48

1.52

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

257

1.48

1.52

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

257

1.48

1.52

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.34

1.52

1.2

1.1

—

(40768793) Breast Pathology biopsy report

621

0.71

1.52

1.4

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

740

1.28

1.50

1.2

1.3

u/l

20.2

40.6

2.30

641

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

446

1.35

1.44

1.0

1.1

u/ml

7.1

3.1

0.78

207

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.73

1.43

1.2

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.73

1.43

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

120

980

1.23

1.41

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.18

1.39

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

581

5334

1.10

1.39

1.4

—

(3017509) Phencyclidine [Presence] in Urine

2.42

1.39

2.3

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

111

1.71

1.38

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.61

1.36

1.5

1.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

2.8

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

761

1.25

1.34

1.2

1.3

miu/ml

164.2

207.4

0.70

302

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

646

1.27

1.33

1.2

u/ml

25.2

41.3

—

(3016018) Differential panel - Cerebral spinal fluid

427

1.34

1.33

1.1

1.4

—

(3011412) CD3 cells [#/volume] in Blood

393

1.35

1.32

2.2

2.4

e9/l

1.3

1.1

0.92

229

(3009871) Measles virus Ab [Titer] in Serum

122

1.64

1.27

1.6

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.29

1.26

3.6

2.6

u/field

0.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.63

1.23

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.00

1.23

1.6

1.4

—

(4094501)

107

1295

0.82

1.22

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

296

3306

0.89

1.20

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

272

1.40

1.19

1.1

mg/l

339.6

321.3

0.09

231

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.88

1.18

1.3

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.88

1.18

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.16

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.00

1.16

1.5

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

257

1.40

1.15

3.7

2.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

550

5095

1.09

1.12

5.1

4.5

32.9

31.9

1.11

416

3457

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.00

1.12

1.0

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

108

1292

0.83

1.11

1.6

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

276

1.38

1.11

2.3

2.5

e6/l

624.5

523.9

0.57

237

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.38

1.09

2.0

1.5

mmol/l

20.1

25.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

162

0.55

1.08

1.6

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.08

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

236

1.40

1.06

8.4

6.3

u/ml

44.0

12362.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.71

1.05

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

297

1.35

1.04

2.3

2.1

14.4

14.9

0.07

124

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.27

1.03

9.0

10.7

—

(4268621)

402

1.30

1.03

2.1

2.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.92

1.02

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

281

1.36

1.01

2.5

2.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

281

1.36

1.01

1.2

1.1

mg/l

50.7

46.0

0.19

228

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.69

1.01

1.8

1.5

ug/l

0.3

0.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.65

1.00

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

250

0.64

1.00

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.00

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

164

1.47

0.99

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.71

0.98

1.6

1.4

12.5

7.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.95

0.97

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.80

0.96

1.2

1.3

—

629.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.80

0.96

1.1

—

(44806420)

108

1.58

0.96

1.9

2.3

—

(3036603) Volume of Urine

276

1.34

0.95

1.6

1.8

1801.4

1835.5

0.05

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.89

0.94

3.9

1.4

umol/l

62.1

38.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.89

0.94

2.1

3.7

g/mol

88.9

19.9

—

(1175426) CD3 cells/100 lymphocytes in Blood

303

1.32

0.93

2.4

2.1

77.2

72.1

2.02

288

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.22

0.93

1.2

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

252

1.35

0.91

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

118

1.53

0.90

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.60

0.90

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.75

0.90

1.4

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3849

38948

0.95

0.87

4.7

4.1

mmol/l

1.5

1.3

9.33

3505

35671

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

494

1.24

0.87

1.4

1.6

58.0

62.6

0.34

316

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.94

0.84

5.3

2.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.94

0.84

2.0

2.5

—

(3010503) CD19 cells [#/volume] in Blood

265

1.32

0.84

1.8

2.5

e9/l

0.2

0.09

257

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

146

1.44

0.82

2.2

3.0

umol/l

28.0

28.8

0.10

110

(40768795) Lymph node Pathology biopsy report

392

1.25

0.79

1.1

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.67

0.78

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

124

0.56

0.77

1.1

1.5

—

(3006462) Nitrate [Presence] in Urine

165

1.40

0.77

3.6

3.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.3

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.64

0.75

2.7

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

736

1.17

0.73

2.7

3.0

nmol/l

0.9

0.8

0.45

554

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.62

0.71

1.1

1.2

82.5

78.5

—

(44806071)

1.71

0.70

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.53

0.68

1.0

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.64

0.68

1.2

1.1

—

(3014891) Appearance of Pleural fluid

1.53

0.68

1.2

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

107

938

1.14

0.67

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

136

1.40

0.66

1.1

1.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

136

1.40

0.66

3.0

2.2

33.1

28.8

0.74

126

(3023410) Appearance of Cerebral spinal fluid

393

1.22

0.66

1.3

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.79

0.66

1.8

2.6

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.72

0.64

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

198

1.31

0.64

1.0

1.1

u/l

1.3

1.1

—

106

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

104

1.44

0.62

1.1

1.3

28.4

28.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.55

0.62

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

144

1296

1.11

0.62

1.7

1.9

pmol/l

205.2

207.6

0.12

137

1223

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.67

0.61

1.0

—

(4211845)

182

1.32

0.61

3.5

3.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.60

1.3

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

131

1.38

0.59

7.2

7.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

112

0.62

0.58

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

112

0.62

0.58

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

112

0.62

0.58

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

112

0.62

0.58

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

167

1.32

0.56

1.7

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

274

1.24

0.56

1.7

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

356

1.21

0.56

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.46

0.56

1.1

—

(4034850)

119

1324

0.90

0.56

16.6

9.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.54

0.55

2.0

2.2

umol/l

14.7

19.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.46

0.54

1.1

—

(3015183) Erythrocyte sedimentation rate

170

0.71

0.53

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

134

1.34

0.53

2.1

2.0

—

(3034426) Prothrombin time (PT)

143

1.33

0.52

1.2

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.43

0.52

1.4

2.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.38

0.50

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.41

0.50

1.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

424

4032

1.06

0.50

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.46

0.50

1.2

1.7

nmol/l

0.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

118

1.36

0.50

7.3

7.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

136

1.32

0.49

3.4

2.1

8.2

10.1

0.52

123

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.45

0.48

1.0

1.2

—

182.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

137

1.32

0.47

1.6

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

654

1.13

0.47

1.8

1.5

—

(3016228) CD19 cells/100 cells in Blood

173

1.27

0.46

1.9

2.1

8.5

8.1

0.07

167

(3020650) Glucose [Presence] in Urine

103

1.36

0.45

1.2

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

100

904

1.11

0.44

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

694

0.88

0.44

1.5

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

512

0.86

0.43

1.0

1.1

u/ml

2.9

4.4

0.49

256

(3051593) INR in Capillary blood by Coagulation assay

211

1.23

0.43

9.0

10.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

574

0.87

0.42

1.0

1.1

u/ml

1.9

0.01

241

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.38

0.41

1.1

1.3

nmol/l

3.0

565965.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.2

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

2.1

—

(4024509)

361

1.16

0.40

1.8

1.5

—

(4038314)

0.00

0.40

0.0

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.43

0.39

1.2

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.39

0.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

324

0.83

0.39

1.0

u/ml

0.3

0.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

391

1.15

0.38

1.4

1.5

23.1

27.9

0.45

246

(3026480) Teichoate Ab [Titer] in Serum

1.39

0.38

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

1.39

0.36

2.1

2.4

ug/l

2.9

4.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.43

0.35

2.7

1.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

126

1.27

0.35

3.1

2.1

ug/l

2.5

1.1

0.71

116

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.40

0.35

1.0

1.2

mg/l

6.1

7.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.40

0.35

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

469

0.87

0.35

1.2

mmol/l

9.0

7.4

1.30

341

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.32

0.33

1.1

—

(3025130) Human papilloma virus identified in Specimen

232

0.82

0.33

1.6

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

127

1.26

0.33

1.1

1.3

—

22.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

914

1.08

0.32

1.4

iu/l

23.0

27.5

0.84

760

(3008401) Mugwort IgE Ab [Units/volume] in Serum

497

0.88

0.32

1.0

1.1

u/ml

0.3

1.2

1.97

212

(3037556) Urate [Mass/volume] in Serum or Plasma

143

0.77

0.32

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

324

1.14

0.30

1.5

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

222

1.17

0.29

1.1

nmol/l

4.6

5.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

387

0.88

0.28

1.0

1.1

u/ml

5.6

2.1

0.54

150

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

103

1.26

0.28

3.3

6.8

61.0

73.7

—

(3045414) Leukocytes [Presence] in Urine

183

1741

1.05

0.27

2.0

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

488

0.90

0.25

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

878

1.07

0.25

2.3

2.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.32

0.23

9.2

9.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

136

0.81

0.23

2.0

1.8

—

(3007916) DNA double strand Ab [Titer] in Serum

1.28

0.23

2.8

1.3

—

102.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.25

0.22

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.22

0.22

3.4

2.1

—

(3026470) Cobalt [Mass/volume] in Blood

284

0.88

0.22

1.9

2.0

ug/l

1.7

3.4

3.09

239

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.19

0.21

1.0

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.19

0.21

1.4

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

103

0.78

0.21

2.5

2.3

—

(4212803)

1.16

0.21

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

335

0.89

0.20

1.0

ng/l

195.4

317.3

5.08

243

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

166

0.84

0.20

1.4

1.9

ug/l

22.4

211.5

0.68

148

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

219

0.87

0.20

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(3045142) Bone marrow Pathology biopsy report

501

1.08

0.19

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

310

1.10

0.17

1.9

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.13

0.17

1.4

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

465

0.92

0.17

1.0

u/ml

1.6

2.1

—

107

(3023430) Cat dander IgE Ab [Units/volume] in Serum

351

0.91

0.17

1.0

u/ml

2.0

3.4

0.65

139

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

336

0.92

0.13

1.0

ng/l

28.0

44.1

2.98

239

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

170

1.12

0.13

1.1

—

(3025577) Chromium [Mass/volume] in Blood

273

0.92

0.13

1.9

2.1

ug/l

1.3

2.1

1.98

225

(3017446) Testosterone [Moles/volume] in Serum or Plasma

443

4503

0.98

0.12

2.2

nmol/l

13.8

13.3

0.70

382

4003

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.18

0.12

3.1

3.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.18

0.12

1.1

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

334

0.93

0.12

1.0

ng/l

870.3

717.0

0.88

232

(3045424) Erythrocytes [Presence] in Urine

670

1.05

0.11

1.6

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

209

0.91

0.11

3.6

6.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

0.91

0.09

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

625

0.96

0.09

1.3

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

155

0.90

0.09

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

311

1.06

0.09

1.5

nmol/l

0.3

0.2

0.34

238

(4133840)

123

0.89

0.08

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

0.82

0.07

1.3

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

242

2387

1.01

0.06

1.3

au/ml

30.0

59.1

—

113

(44813793)

237

1.06

0.05

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

476

0.97

0.05

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3954

39586

0.99

0.05

5.8

4.6

mmol/l

7.0

6.0

112.52

3626

36048

(3051387) C reactive protein [Mass/volume] in Capillary blood

848

0.98

0.05

4.3

3.2

mg/l

28.2

0.00

523

(3036071) Salmonella sp Ab [Titer] in Serum

120

1.08

0.04

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

292

0.96

0.04

2.7

5.3

u/ml

41.3

51.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

219

1.05

0.04

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

261

2633

0.99

0.04

2.4

au/ml

28.4

23.3

—

120

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

174

1727

1.01

0.02

1.6

1.8

nmol/l

44.0

40.5

0.94

169

1669

(3008898) HLA-B27 [Presence]

107

1080

0.99

0.01

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

127

0.94

0.01

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

542

1.01

0.01

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.02

0.00

8.4

7.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

127

1.02

0.00

1.5

1.2

g/l

39.6

39.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

306

1.01

0.00

2.0

1.5

g/l

0.9

1.0

0.16

306

(3024263) Appearance of Synovial fluid

243

0.99

0.00

1.3

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.01

0.00

1.2

1.3

—

(40765096) Chromosome analysis panel by Banding

141

0.99

0.00

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

179

1.01

0.00

1.6

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

541

1.00

0.00

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.6

—

0.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

317.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1788.3

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.0

—

44.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.94

0.00

1.4

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.99

0.00

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.93

0.00

1.6

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.02

0.00

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.96

0.00

1.2

1.6

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.99

0.00

1.0

1.1

—

3.6

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.90

0.00

1.3

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.3

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

40.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_CHRONPANC and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_CHRONPANC	4.363 [3.88, 4.9]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.197

During the follow-up period (1.1.1998 — 31.12.2019), 3230 out of 8097 females with K11_CHRONPANC died.

Males

Parameter	HR [95% CI]	p-value
K11_CHRONPANC	4.37 [3.99, 4.79]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 8192 out of 20710 males with K11_CHRONPANC died.

Mortality risk

Mortality risk for people of age

years, who have K11_CHRONPANC.

N-year risk	Females	Males
1	0.393%	0.649%
5	2.528%	4.404%
10	6.237%	10.43%
15	12.667%	19.633%
20	19.991%	31.006%

Relationships between endpoints

↥

Index endpoint: K11_CHRONPANC – Chronic pancreatitis

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Chronic pancreatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints